Author Index for Volume 41

Author Index For Volume 41

Aakhus S (abst) 507 Abboud HE: Platelet-derived growth factor and mesan581 gial cells Abe K See Ogahara S et al 175 Abraham WT See Hensen J et al 1333 Abramovici M See Singhal PC et al 1560 Abrass CK (abst) 705 Adams S See Vlahakos DV et at 1690 Adcox MJ (abst) 705 Adler SG (abst) 700, 705 Adler SG See Ihm C-G et al 768 Aeo G (abst) 1463 Ahlstrand C (abst) 510 Ahn CI (abst) 1453

Alvarez Ri, Sun Mi, Haverty TP, lozzo RV, Myers JC, Neilson EG: Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with 14 paracrine cytokines Ambroso G (abst) 1446 Amento E (abst) 696

AhnDW(abst)

1451

AkarU(abst)

1472

Arnie! C See Bailly C et a! 269 Amieva M See Furthmayr H et at 665 Ammer U (abst) 478 Amrani A See Baud L et al 600 An SJ (abst) 1455, 1464, 1464 Ancarani P (abst) 1446 Andersen CB (abst) 508 Andersen HK (abst) 510 Andersen NF (abst) 505 Andersen T (abst) 513 Anderson A See Morgan TO et al 36:S-78 Anderson PH See Hansen KW et al 847 Anderson PS (abst) 700 Anderson S, Rennke HG, Brenner BM, Zayas MA, Lafferty HM, Troy JL, Sandstrom Di: Nifedipine versus fosinopril in uninephrectomized diabetic

1470 Akbay E (abst) 1473 Akçay G (abst) 1470 Akoglu E (abst) 1470 Akoglu T (abst) 1470 Akpolat T (abst) 1471 Akyazici P (abst) Alarabi AA (abst) 501 499 Alaupovic P (abst) Albers C (abst) 488 Albini F See Parati G et a! 37:S-24 Alexiewicz JM See Chervu I et al 1501 Alinovi R See Khalil-Manesh F et al 1192 A1-Khateeb M See Said R et a! 414 Alkim H (abst) 1472 Allan PL See Watson ML et al 206 1444 Allegra A (abst) Allemann Y (abst) 481 Allen T See Jerurns G et al 904 Allen Ti See Cooper ME et a! 898 Almeida ARP, Wetzels JFM, Bunnachak D, Burke Ti, Chairnovitz C, Hammond WS, Schrier RW: Acute phosphate depletion and in vitro rat proximal tubule 1494 injury: Protection by glycine and acidosis Aloisi C (abst) 1444 1470 Alpdogan O (abst) 701 Alpers CE (abst) Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of "muscle-specific" actin in 1134 glomerulonephritis Alpers CE See Floege J et al 297 Altrnann J-J See Mal F et al 445 A1-Uzri A, Holliday MA, Gambertoglio JG, Schambelan M, Kogan BA, Don BR: An accurate practical method for estimating GFR in clinical studies using a 1701 constant subcutaneous infusion (Technical Note)

Andrassy K (abst) 478, 488, 490, 700 Andreoli TE: Kidney International: Perspectives from the editors 1 494 Angielski S (abst) Angus iA, Dyke AC, Jennings GL, Korner P1, Sudhir K, Ward iE, Wright CE: Receptor-stimulated release of endothelium-derived relaxing factor from resistance arteries in hypertension 37:S-73 Angus JA See Korner PT et al 37:S-38 Anidjar S, Osborne-Pellegrin M, Coutard M, Michel J-B: Arterial hypertension and aneurysmal dilatation 37:S-61 Antonucci F (abst) 1443 1467 Apak H (abst) 478 Apenberg S (abst) 1436 Apperloo AJ (abst) Arakawa K See Ogahara S et a! 175 Arakawa M See Hayashi H et al 749 Ardaillou N See Stefanovië V et a! 1571 Ardaillou R (abst) 480 Ardaillou R, Bens M, Edgington TS: Glomerular tissue factor stimulates thromboxane synthesis in human 361 platelets via thrombin generation Ardaillou R See Stefanovië V et al 1571 Argiles A See Kerr PG et a! 1035 Arik N (abst) 1469, 1470, 1471, 1472 Arinsoy I (abst) 1469, 1470, 1471, 1472 1469 Arisoy E (abst) 1467 Arisoy N (abst) . 1469 Arisoy S (abst) Arisz L (abst) 1433, 1436, 1437, 1437 Arisz L See Struijk DG et a! 1668 1466, 1473 Ark E(abst) 697 Armelloni S (abst) 1055 Arminio A See Muller GY et al

Ahn JH (abst) 1449, 1449, 1452, 1454, 1456, 1462 Ahn SH (abst) 1465 Ahn Si (abst) 1448, 1465 Ahonen J See Isoniemi HM et a! 155 1441 Airaghi C (abst)

rats

1749

891

Author index:

1750

Arnolda L, Minson J, Kapoor V, Pilowsky P, Liewellyn-Smith I, Chalmers J: Amino acid neuro37:S-2 transmitters in hypertension Aronson PS (abst) 485 Arslan N (abst) 1469 1470 Arsian S (abst) 700, 705 Artishevsky A (abst) Artishevsky A See Ihm C-G et a! 768 488 Asmus 0 (abst) Assmann KJM (abst) 1430, 1432 Assmann KJM See van den Born J et a! 115 Ataman R (abst) 1466, 1466, 1467 Attawia MA See Nayak RC et a! 1638 Attman P.O (abst) 499 492 Aulmann G (abst) 506 Aunsholt NA (abst) Aurell M (abst) 500, 512, 512 Aurell M, Björck S: Determinants of progressive renal disease in diabetes mellitus 36:S-38 Austin HA See Choyke PL et a! 1595 855 Avogaro A See Trevisan R et a! 1473 Avsar T (abst) 1466, 1466 Ayaz M (abst) 1470 Ayaz S (abst) 1471 Aydin AE (abst) 1467 Aykaç B (abst) Aynedjian HS See Wilkes BM et al 992 700 Ayo SH (abst) 1466, 1467, 1473 Aysuna N (abst) 485 Bach D (abst) Bachman S, Peters J, Engler E, Ganten D, Mullins J: Transgenic rats carrying the mouse renin gene—Morphological characterization of a low-renin hyperten24 sion model Bachmann S (abst) 478, 496 Backman U (abst) 507, 512 1446 Badalamenti S (abst) Badr KF See Fischer DB et al 1155 Badr KF See Takahashi K et al 1245 1462 Bae HM (abst) Bae HY (abst) 1463 700 Baelde JJ (abst) 1441, 1443 Bagni B (abst) 482 Bahner U (abst) Baier LD See Tilton RG et al 778 1535 Bailey J See May RC et al Bailly C, Bartlet-Bas C, Amiel C: Platelet activating factor inhibits Cl and K transport in the medullary thick ascending limb 269 723 Bak M See Barzilay .1 et al Bakan E (abst) 1472 1470, 1470 Bakkaloglu A (abst) 115 Bakker MAH See van den Born J et al Bakris GL, Barnhill BW, Sadler R: Treatment of arterial hypertension in diabetic humans: Importance of 912 therapeutic selection Balat A (abst) 1468 Baldari S (abst) 1444 Ballardie FW See Brenchley PE et al 933 Balimer PE, Weber BK, Roy-Chaudhury P, McNurlan MA, Watson H, Power DA, Garlick PJ: Elevation of albumin synthesis rates in nephrotic patients measured with l1-'3C]leucine 132 Bang BK (abst) 1448, 1455, 1457, 1460, 1460, 1463, 1464, Bang DS (abst)

1464, 1464, 1464, 1464, 1465

1456

Vol. 41

703 Bangstad H-J (abst) 920 Bangstad HJ See Dahl-JØrgensen K et al 992 Bank N See Wilkes BM et a! Baranowski RL (abst) 699 503, 504, 504, 505 Bárány P (abst) 512 Bardelli M (abst) Barfuss DW, McCann WP, Katholi RE: Axial heterogeneity of adenosine transport and metabolism in the 1143 rabbit proximal tubule 503 Barkeling B (abst) 912 Barnhill BW See Bakris GL et al Barrès C, Julien C, Sassard J: Arterial pressure control in the sympathectomized rat 37:S-19 Barrett BJ, Parfrey PS, Vavasour HM, McDonald J, Kent G, Hefferton D, O'Dea F, Stone E, Reddy R, McManamon PJ: Contrast nephropathy in patients with impaired renal function: High versus low osmo1274 lar media Barrett GL, Mullins JJ: Studies on blood pressure regu37:S-125 lation in hypertensive ren-2 transgenic rats 1690 Barrett KJ See Vlahakos DV et al 478 Bartel C (abst) 269 Bartlet-Bas C See Bailly C et al Barzilay J, Warram JH, Bak M, Laffel LMB, Canessa M, Krolewski AS: Predisposition to hypertension: Risk factor nephropathy and hypertension in 723 IDDM 1445 Basler V (abst) 166 Batile DC See Nutting CW et al 495 Batsford S (abst) 1468 Batur N (abst) Baud L (abst) 698 Baud L, Fouqueray B, Philippe C, Amrani A: Tumor 600 necrosis factor alpha and mesangial cells Baudoin P (abst) 1437 492 Baum RP (abst) 484 Baumann K (abst) Bäumer K (abst) 482 478 Baumgart P (abst) 701 Baumgartner S (abst) Bazzi C (abst) 1445 445 Beaugrand M See Ma! F et a! 494 Beck FX (abst) Beck-Gessert S (abst) 705 1008 Beckman JK See Yoshioka T et al

BedaniPL(abst)

1441, 1443

Behrend M (abst) 484 Beilin U: Dietary salt and risk factors for cardiovascular disease 37:S-90 1468, 1470 Beksac M (abst) 613 Bennett R See Hogg N et al 361 Bens M See Ardai!lou R et al Benstein JA See Lax DS et a! 1527 1439 Berardinelli L (abst) Berdeaux A, Duranteau J, Pussard E, Edouard A, Giu— dicelli J-F: Baroreflex control of regional vascular resistances during simulated orthostatism 37:S-29 Berden JHM (abst) 1432 Berden JHM See Elving LD et al 862 Berden JHM See van den Born J et a! 115 Berg KJ (abst) 500, 507, 703 512 Berg U (abst) Bergamaschi E See Khalil-Manesh F et a! 1192 496 Berger B (abst) 700 Bergijk EC (abst) Bergijk EC See Bruijn JA et a! S

Author Index: Vol. 41

Bergstrand A (abst) 507, 511, 511 Bergstrom J (abst) 501, 503 Bergstrom J See Canepa A et a! 1016 Ben T, Mansour J, Veis JH: Regulation of atrial natriuretic peptide-stimulated cGMP production in the inner medulla 37 Bernasconi P (abst) 697 Berney T See Lemoine R et al 65 Berto P See Ronco C et a! 1383 Bertocchi C See Gaspari F et a! 1081 Bertolissi M (abst) 1443

Beba N (abst)

1470, 1470

BoerP(abst)

1430, 1435 1430 1442, 1442 702

Bettini MC See Ronco C et a! 1383 Betz M (abst) 486 Beuve CS, Leclercq C, Rannou F, Oliviero P, Mansier P, Chevalier B, Swynghedauw B, Charlemagne D: Remodeling of the heart (membrane proteins and col37:S-45 lagen) in hypertensive cardiopathy Bianco NE See Muller GY et a! 1055 Bianco P See Kopp JB et al 56 Bichara M See Houillier P et al 1182 Biel K (abst) 493 Bieneck S (abst) 494 1473 Bilgel H (abst) Bindels RIM (abst) 1434 491 Binswanger U (abst) 507 Birgegârd G (abst) BjOrck S See Aurell M et a! 36:S-38 BjØro T See Dahl-JØrgensen K et al 920 1437 Blankenstijn PJ (abst) Blaser C (abst) 479, 498 Bleck J (abst) 487 Blin P See Ramboer I et al 37:S-67 Blumberg A, Weidmann P, Ferrari P: Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure 369 Bobik A See Korner P1 et al 37:S-38 Bock HA (abst) 498 Bock HA, Herm!e M, Brunner FP, Thiel G: Pressure dependent modulation of renin release in isolated perfused glomeruli 275 Bocker G (abst) 1434 Boeckmann W (abst) 492 Boer K (abst) 1437 Boer WH (abst)

BoeroR(abst)

Boes A (abst) Boes A See Wolthuis A Ct al 124 1430 Bogman MJJT (abst) Bognetti E See Jones SL et al 1620 Bohie A (abst) 484 BOhler J (abst) 479 Bohman S-O (abst) 512 Boland R (abst) 479 Bollen C (abst) 479 Bonanno N (abst) 1444 Bonara P (abst) 1439 Bonilla-Felix M, Hamm LL, Herndon J, Vehaskari VM: Response of cortical collecting ducts from rem1150 nant kidneys to arginine vasopressin Bonj our J-P See Pedrotti A et al 80 Borch-Johnsen K, NØrgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving H-H: Is diabetic 719 nephropathy an inherited complication9

1751

Border WA, Noble NA, Yamamoto T, Tomooka S, Kagami S: Antagonists of transforming growth factor-/3: A novel approach to treatment of glomerulonephritis 566 and prevention of glomeruloscierosis Border WA See Nakamura T et a! 1213 Borensztein P See Houillier P et al 1182 1441 Borgatti PP (abst) Boss C (abst) 495 Bostad L See HoIm J et al 50 Bostedt A (abst) 484 705 Bottomly K (abst) Bourgoignie JJ: Progression of renal disease: Current 36:S-6l concepts and therapeutic approaches Bourgoignie JJ See Green DF et a! 956 Bourgoignie JJ See Green DF et al 1506 Bovio G (abst) 1443 Bowen-Pope DF See Floege J et a! 297 Bowen-Pope DF See Johnson R et al 590 Bozfakioglu S (abst) 1466, 1467, 1473 Bozkirli I (abst) 1473 Brancaccio D (abst) 1443 Brandi L (abst) 501, 502 Brändle E (abst) 478, 479 BrännstrOm M (abst) 502 Brass EP See Hiatt WR et a! 1613 Breborowicz A, Rodela H, Oreopoulos DG: Toxicity of osmotic solutes on human mesothelial cells in vitro 1280 Brecht U (abst) 491, 495 Bred! CR See Zager RA et a! 1588 Brenchley PE, Coupes B, Short CD, O'Donoghue DJ, Ballardie FW, Mallick NP: Urinary C3dg and C5b-9 indicate active immune disease in human membra933 nous nephropathy Brendolan A See Ronco C et a! 1383 Brenner BM See Anderson S et a! 891 Bretzel RG (abst) 479 Breyer MD See Takeda M et al 1713 Brickner ME See Levy FL et a! 961 Briner VA (abst) 699 Briscoe DM See Ford DM et al 1606 Broe MED See Vasilakakis DM et a! 1400 Bronzieri C (abst) 1443 Brown R (abst) 704 Brown Z (abst) 695 Brown!ee AA See Esnault VLM et a! 1304 Brownlee M See Gupta S et a! 1161 Brubacher D (abst) 701 Bruijn JA (abst) 700, 1431, 1432, 1432 Bruijn JA, Bergijk EC, de Heer E, Fleuren GJ, Hoedemaeker PJ: Induction and progression of experimental lupus nephritis: Exploration of a pathogenic path5 way (Editorial Review) 1437 Bruining G (abst) Brunette MG, Mailloux J, Lajeunesse D: Calcium transport by the luminal membrane of distal tubule. II. Effect of pH, electrical potential and calcium channel inhibitors 289 Brunette MG, Mailloux J, Lajeunesse D: Calcium transport through the luminal membrane of the distal tubule. I. Interrelationship with sodium 281 Brunner FP (abst) 498 Brunner FP See Bock HA et a! 275 37:S-79 Brussel EMM-V See Freyss-Beguin MM et al 701 Buch S (abst) Bucht H (abst) 511, 511

1752

Author Index: Vol. 41

Buemi AL (abst) Buemi M (abst) Buhi M (abst) Bunnachak D See Almeida ARP et a! Buoncristiani U (abst) Burke TJ See Almeida ARP et a! Burns A See Spencer SJW et al Burns M (abst) Burns MW See Floege J et al Busse R (abst) Butcher EC (abst) Buur T (abst) Buyan N (abst) Buyssens N (abst) Byun HJ (abst) Byun HY (abst) Cabanas C See Hogg N et a!

1444 1444

caglar S (abst)

1472

ca1ar (abst)

Caglioti A See Canton AD et a! Cahill CJ See Nayak RC et al Calemard E See Charra B et al Ca1ikan S (abst) Callard P See Mat F et al

Cab L (abst)

696 1494 1440 1494 1059 701

297 697 696 502 1473 1435 1459 1456

613 1469, 1470, 1471 951 1638

1286 1467, 1467 445 1443

Calvet JP See Harding MA et a! 317 Calvisi L (abst) 1447 Campbell HT See Rouch AJ et a! 342 Canaud B See Kerr PG et al 1035 Canavese C (abst) 1447 Canepa A, Filho JCD, Forsberg A-M, Perfumo F, Carrea A, Gusmano R, Bergstrom J: Nutritional status and muscle amino acids in children with end-stage renal failure 1016 Canessa M See Barzilay J et a! 723 1441 Cantaluppi A (abst) Canton AD, Fujano G, Sepe V, Caglioti A, Ferrone S: Mesangial expression of intercellular adhesion molecule- 1 in primary glomerulosclerosis 951 1444 Capasso G (abst) Capriles FT See Muller GY et al 1055 Caramelo C (abst) 695 Carbonell ME See Fermindez JM et al 1029 Carin M (abst) 1467, 1471, 1472 Carlsson MS (abst) 510 Carmines PK, Mitchell KD, Navar LG: Effects of calcium antagonists on renal hemodynamics and glomerular function 36:S-43 Carozzi S (abst) 1441 Carrea A See Canepa A et a! 1016 Carroll HJ (abst) 1450 Casado S (abst) 695 Casati S (abst) 1446 Cavallini AR (abst) 1441 Cederhoim B (abst) 509 Cedgárd S (abst) 510 1469 celiker H (abst) 1467 Cerrahpaa IU (abst)

cetin S (abst)

1468

Cha DR (abst)

1455, 1459

ChaFJK(abst) Cha Yl (abst)

1459 1455

Chae DW (abst) Chai KX See Jaffa AA et a! Chaimovitz C See Almeida ARP et a! Chalmers J See Arnolda L et a!

1450, 1452 789 1494

37:S-2

Chalmers JP See Elghozi J-L et al 37:S-l Chan JCM See Santos F et at 356 Chana RS (abst) 699 Chang K See Ido Y et a! 435 1450 Chang KS (abst) Chang YS (abst) 1448, 1455, 1457, 1464, 1464, 1465 Chansel D (abst) 480 Chao J See Jaffa AA et al 789 Chao L See Jaffa AA et a! 789 Charlemagne D See Beuve CS et a! 37:S-45 Charra B, Calemard E, Ruffet M, Chazot C, Torrat J-C, Vanel T, Laurent G: Survival as an index of ade1286 quacy of dialysis Chazot C See Charra B et a! 1286 Chen Y See Rocco MV et a! 107 Chensue SW See Schmouder RL et al 191 Cheon RH (abst) 1450 1454 Cheong HI (abst) Cheong HI See Kieppel MM et al 1629 Cherchi G (abst) 1447 Chervu I, Kiersztejn M, Alexiewicz JM, Fadda GZ, Smogorzewski M, Massry SG: Impaired phagocytosis in chronic renal failure is mediated by secondary 1501 hyperparathyroidism Cheuñg AHS, Sutherland DER, Gillingham KJ, McHugh LE, Moudry-Munns KC, Dunn DL, Najarian JS, Matas AJ: Simultaneous pancreas-kidney transplant versus kidney transplant alone in diabetic 924 patients Chevalier B See Beuve CS et a! 37:S-45 Chi JG (abst) 1453 Chintala MS, Jandhyala BS: Evaluation of the efficacy of felodipine in two models of acute renal failure in 36:S-94 dogs 701 Chiquet M (abst) Chiquet M: Tenascin: An extracellular matrix protein 629 involved in morphogenesis of epithelial organs Cho BS (abst) 1453

Ch0DK(abst)

1457, 1462 1460

Ch0KB(abst)

1461 1451 1455

Cho iT (abst)

Cho KW (abst) Cho SW (abst) Cho WH (abst) Cho WY (abst) Choi EJ (abst) Choi HJ (abst) Choi IJ (abst) Choi iS (abst) Choi KC (abst) Choi KH (abst)

1460

1452, 1455, 1459 1455 1461

1453, 1453, 1463 1461

1451

1448, 1450, 1456, 1458, 1459, 1462, 1463, 1463

Choi SD (abst) 1463 Choi Y (abst) 1454, 1461 Cholmakow K (abst) 483 Choyke PL, Austin HA, Frank JA, Girton ME, Diggs RL, Dwyer AJ, Miller LG, Nussenblatt R, McFarland H, Simon T: Hydrated clearance of gadolinium-DTPA as a measurement of g!omerular filtration rate 1595 Christensen A-L (abst) 503 Christensen CK See Hansen KW et al 847 Christensen CK See Pederson MM et al 883 Christians U (abst) 487 Christiansen JS See Hansen KW et a! 847 Christman JW See Fischer DB et a! 1155

Author Index: Vol. 41

Chu KU (abst) 1460 Chun RW (abst) 1452 1450 Chung CH (abst) 1459 Chung SH (abst) 1453, 1457 Chung TH (abst) 1452 Chung WY (abst) 1454 Chung Y (abst) Ciceri R (abst) 1446 1473 ciftcioglu MA (abst) Cinotti GA (abst) 1442 Cinotti GA See Menè P et al 554 1444 Cinquegrani M (abst) Cintin C (abst) 503 Cipollina MR See Trevisan R et al 855 Ciresi DL, Lloyd MA, Sandberg SM, Heublein DM, Edwards BS: The sodium retaining effects of 1599 cyclosporine

timan B (abst)

695

Claesson-Welsh L See Heldin C-H et al 571 Clement J (abst) 1431 Cloarec-Blanchard L, Girard A, Houhou S. GrUnfeld J-P, Elghozi J-L: Spectral analysis of short-term blood pressure and heart rate variability in uremic 37:S-14 patients Close CF See Walker JD et al 741 504, 504 Clyne N (abst) Coe FL, Parks JH, Webb DR: Stone-forming potential of milk or calcium-fortified orange juice in idiopathic 139 hypercalciuric adults Coers W (abst) 1432 Cofano F (abst) 1446 Coffman TM See Smith SR et al 199 Coffman TM See Spurney RF et a! 973 1439 Cogno C (abst) Cohen AH See Khalil-Manesh F et al 1192 Cohen DI (abst) 483 Cohen Tervaert JW (abst) 1435 1468 coker M (abst) Colantonio G (abst) 1443 Coleman DL (abst) 698 Coleman DL, Ruef C: Interleukin-6: An autocrine regulator of mesangial cell growth 604 Collins DM, Lambert MB, Middleton JP, Proctor RK, Davidson Ci, Newman GE, Schwab SJ: Fistula dysfunction: Effect on rapid hemodialysis 1292 Collins T See Fries JWU et al 584 Colmenares CJ See Muller GY et al 1055 Colombo D (abst) 1439 Colturi C (abst) 1445 Colussi G (abst) 1441 Conte G (abst) 1445 Conz P See Ronco C et at 1383 Cooper ME, Rumble iR, Allen Ti, O'Brien RC, Jerums G, Doyle AE: Antihypertensive therapy in a model combining spontaneous hypertension with diabetes 898 Cooper ME See Jerums G et at 904 Copley iB See Koenig KG et at 161 Correa-Rotter R, Hostetter TH, Manivel IC, Eddy AA, Rosenberg ME: Intrarenal distribution of clusterin following reduction of renal mass 938 Correa-Rotter R, Hostetter TH, Rosenberg ME: Renin and angiotensinogen gene expression in experimental 796 diabetes metlitus 396 Cosio FG See Nahman NS Jr. et al 1445 Cosseddu D (abst)

1753

Coupes B See Brenchley PE et al 933 Couser WG (abst) 701 Couser WG See Floege J et al 297 Coutard M See Anidjar S et al 37:S-61 1433 Couttenye MM (abst) Creech EA See Smith SR et al 199 Crepaldi G See Fioretto P et a! 813 Crepaldi G See Trevisan R et at 855 Cristinelli L (abst) 1440, 1440 Crowley S See Gupta S et at 1161 699 Cumming AD (abst) Cura A (abst) 1467, 1468 Curatola A (abst) 1442, 1443 Cushner HM See Koenig KG et at 161 Cuzic S (abst) 480, 701 Cuzzota F (abst) 1442, 1443 480 Czekalski S (abst) Daerr WH (abst) 480 1442 D'Agostino A (abst) D'Agostino A See Menè P et al 554 Daha MR (abst) 695, 1431, 1435 Dahl E (abst) 509 Dahi K (abst) 507 Dahl-JØrgensen K, BjØro T, Kierulf P, Sandvik L, Bangstad Hi, Hanssen KF: Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus 920 703 Dahl-JØrgensen K (abst) 822 Dahiquist G See Rudberg S et al 482 Dakshinamurty KY (abst) Dalmak S (abst) 1466, 1466 Dalva I (abst) 1468, 1470 Dalva K (abst) 1468, 1470 D'Amico G (abst) 697, 1445, 1446, 1447, 1447 Dämmrich I (abst) 482 Damsgaard EM, FrØland A, iØrgensen OD, Mogensen CE: Eight to nine year mortality in known non-insulin dependent diabetics and controls 731 Daniel TO, Kumjian DA: Platelet-derived growth factor 575 receptors and phospholipase C activation Danielson BG (abst) 500, 501, 501, 504, 504, 506, 507, 509, 512

Daret D See Ramboer I et al 37:S-67 Datta SK See Vlahakos DV et al 1690 Daugaard H (abst) 501, 501, 502, 512 Daugirdas JT See Nutting CW et al 166 Daul A (abst) 488 David C (abst) 480 Davidson CJ See Collins DM et at 1292 Davies iE See Ng LL et a! 872 Davies M (abst) 699 Davies M, Martin J, Thomas GI, Lovett DH: Proteinases and glomerular matrix turnover 671 Davies RW (abst) 1438 de Boland A (abst) 479 De Broe ME (abst) 1433, 1435 706 de Crombrugghe B (abst) De Ferrari ME (abst) 1441 de Heer E (abst) 1430 de Heer E See Bruijn JA et a! 5 1436 de Jong PE (abst) 1436 de Leeuw PW (abst) 1443 De Paoli Vitali E (abst) 862 Dc Pont JJHHM See Elving LD et al 1445 De Rango E (abst) 1432 De Ridder L (abst)

1754

Author Index: Vol. 41

1433 de Rooy-Roggekamp MC (abst) de Vries PMJM See Kouw PM et al 440 de Wolff FA (abst) 1432 de Zeeuw D (abst) 1436 de Zeeuw D, Janssen WMI, Jong PE: Atrial natriuretic factor: Its (patho)physiological significance in humans 1115 (Editorial Review) Dean JD See Vora JP et al 829 Decaux G See Soupart A et a! 1662 Deckert T See Borch-Johnsen K et a! 719 Deferrari G (abst) 1446 1442, 1442 Degli Esposti E (abst) 488 Deja A (abst) DelBo A (abst) 1446 Delmez JA, Windus DW: Hemodialysis prescription 1023 and delivery in a metropolitan community Demirel F (abst) 1473 den Ottolander GJFI (abst) 1433 480 Dengler HJ (abst) 480 Dengler TJ (abst) Denneberg T (abst) 502, 510, 510 Denton DA See Tarjan E et al 37:S-97 DePierre JW (abst) 507 486 Deppisch R (abst) Derkx FHM (abst) 1437 Dermietzel R See Minuth WW et al 215 Dern K (abst) 479 Desmoulière A, Gabbiani G: The cytoskeleton of arterial smooth muscle cells during human and experimental artheromatosis 37:S-87 D'Haese PC (abst) 1433 D'Haese PC See Vasilakakis DM Ct al 1400 Di Dio F (abst) 1443 1444 Di Filippo S (abst) Di Gennaro C (abst) 1445 Di Rienzo M See Parati G et al 37:S-24 DiBona GF, Epstein M, Mann JS, Nordlander M: Introduction 36:S- 1 Diet! P (abst) 488 Dietz JR See Ramirez G et al 334 Digenis PN See Vasilakakis DM et a! 1400 Diggs RL See Choyke PL et at 1595 1430 Dijkstra C (abst) Dilek K (abst) 1466, 1468 Dinarello CA: Cytokines: Agents provacateurs in 683 hemodialysis9 Distler A (abst) 484, 484, 485, 696 Dixit VM: Thrombospondin and tumor necrosis factor 679 486 Djurup R (abst) Dodds R See Jones SL et a! 1620 1447 Dogliani M (abst)

Dolben J See Vora JP et at Dolman KM (abst) Don BR See A1-Uzri A et a! Donadon V See Trevisan R et a! Donker AJM (abst) Donker AJM See Kouw PM et al Donohoe JF: Scleroderma and the kidney (Nephrotogy Forum) DOrge SE (abst) Dorhout Mees EJ (abst)

829 1431 1701

855 1433

440 462 481 1430 855

Doria A See Trevisan R et at Doucet A: Na-K-ATPase in the kidney tubule in relation to natriuresis 37:S-1 18 Douglas FL See Smith SR et al 199

Douglass D See Neufeld TK et al Douma CE (abst) Dousa TP See Rassier ME et al Downie I See Gibson 1W et a! Downie TT See Gibson 1W et a! Doyle AE See Cooper ME et al Draaijer P (abst) Draaijer P See Kooman JP et al Dransfield I See Hogg N et al Drenckhahn D (abst) Duley IT See Gabow PA et al Duman N (abst) Dündar S (abst) Dunn DL See Cheung AHS et al Dunn MJ See Simonson MS et al Duranay M (abst) Duranteau J See Berdeaux A et al DUrer Z (abst) Dürr J See Hensen J et a! Duva! DP See Freyss-Beguin MM et a! Dworkin LD See Lax DS et a! Dworkin LD See Weisstuch JM et a! Dwyer AJ See Choyke PL et al Dyke AC See Angus JA et al Eason J See Moore KP et al Eberlein-Gonska M (abst) Ebert J See Takahashi K et a! Ecder ST (abst) Eckardt K-U (abst) Eddy A (abst) Eddy AA See Correa-Rotter R et al Edefonti A (abst) Edgar B See Elmfeldt D et a! Edgington TS See Ardaillou R et a! Edouard A See Berdeaux A et al Edwards BS See Ciresi DL et a! Egfjord M (abst) Egido J (abst) Egsmose C (abst) Ehmer B (abst) Ehmke H (abst) Ehsani N (abst) Eidemak I (abst) Eiskjer H See Pedersen EB et al Ejerbiad S (abst) Ekblom P (abst) Ekblom P See Sorokin L et a! Ekim M (abst) Ekinci A (abst) El Yandouzi EH See Vrtovsnik F et at

Elbai A (abst)

1222 1437 88 211 211 898 1433 1041

613 696 1311

1469

1470, 1471, 1472 924 542 1469

37:S-29 1468 1333

37:S-79 1527

36:S-33 1595

37:S-73 1543

490, 700 1245 1466, 1473 481 701

938 1439

36:S-54 361

37:S-29 1599

501, 508, 512 695 501, 502 493

481, 490 696 505, 505, 505 36:S-82 512 705 657 1471

1467 983 1467 1467, 1471

Eldegez U (abst) 481, 696 Elger M (abst) Elghozi J-L, Chalmers JP: Introduction 37:S-1 Elghozi J-L See Cloarec-Blanchard L et at 37:S-14 Eli A (abst) 1439 Elliott TG See Messent JWC et a! 836 Elmfeldt D, Nordlander M, Edgar B: Renal effects of 36:S-54 felodipine—A review Elving LD, Wetzels JFM, De Pont JJHHM, Berden JHM: Is increased erythrocyte sodium-lithium countertransport a useful marker for diabetic 862 nephropathy9 Emanuelsson B-M (abst) 510 Emmendorffer A (abst) 698 Endou H See Nosaka K et a! 73

Author Index: Vol. 41

Endresen L (abst) 507 England B See May RC et a! 1535 Engler E See Bachman S et al 24 482 Engler-Blum G (abst) Ensari C (abst) 1471 1445 Epper R (abst) Epstein M: Calcium antagonists and the kidney: Implications for renal protection 36:S-66 Epstein M See DiBona GF et al 36:S-1 Erbas B (abst) 1469 1469 Erbay B (abst) 1473 Erbengi T (abst) Erden M (abst) 1467 Erduran E (abst) 1471 Erek E (abst) 1466, 1466 Eren Z (abst) 1467 Eriksson A See Heldin C-H et a! 571 495 Erley C (abst) Erley CM, Harrer U, Kramer BK, Risler T: Renal hemodynamics and reduction of proteinuria by a Vasodilating beta blocker versus an ACE inhibitor 1297 Ernest I (abst) 510 Ernst W (abst) 479, 498

1755

Ferrero M (abst) 1447 Ferrone S See Canton AD et al 951 Fidler V (abst) 1431 697 Figliuzzi M (abst) Fi!ho JCD See Canepa A et al 1016 Findon G See Miller TE et al 1356 Fioretto P, Muollo B, Faronato PP, Opocher G, Trevisan R, Tiengo A, Mantero F, Remuzzi G, Crepaldi G, Nosadini R: Relationships among natriuresis, atrial natriuretic peptide and insulin in insulin-dependent diabetes 813 Fioretto P See Trevisan R et al 855 Fischer DB, Christman JW, Badr KF: Fifteen-S-hydroxyeicosatetraenoic acid (1 5-S-HETE) antangonizes the chemotactic action and glomerular synthesis of leukotriene B4 in the rat 1155 Fischer J (abst) 484, 484 Fischer P (abst) 492 FitzGerald GA See Remuzzi G et a! 1483 Flanigan Mi See Symreng T et al 1064 Flatmark A (abst) 509 Flavier J-L See Kerr PG et a! 1035 699, 701 1469 Fleming S (abst) ErolC(abst) 5 Erol 0 (abst) 1466 Fleuren GJ See Bruijn JA et al 701 Floege J (abst) Esnault VLM, Soleimani B, Keogan MT, Brownlee Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl AA, Jayne DRW, Lockwood CM: Association of 1gM P, Gordon K, Seifert RA, Bowen-Pope DF, Couser with IgG ANCA in patients presenting with pulmoWG, Johnson Ri: Glomerular cell proliferation and 1304 nary hemorrhage PDGF expression precede glomerulosclerosis in the 695 Espinosa U (abst) remnant kidney model 297 Eum SH (abst) 1451 Floege J See Johnson R et al 590 Ewert BH, Jennette JC, Falk RJ: Anti-myeloperoxidase Flyvbjerg A, Marshall SM, Frystyk J, Hansen KW, antibodies stimulate neutrophils to damage human Harris AG, Ørskov H: Octreotide administration in endothelial cells 375 diabetic rats: Effects on renal hypertrophy and uriFabbri A (abst) 1442, 1442 nary albumin excretion 805 Fadda GZ See Chervu I et a! 1501 510 1440 Foged N (abst) Fagugli RM (abst) 1008 Fahrenholz F (abst) 1430 Fogo A See Yoshioka T et a! Fairbanks LD (abst) 700 695 Foidart JM (abst) Falk RJ See Ewert BH et al 37:S-51 375 Folkow B See Lever AF et al Fan P-Y See Spurney RF et a! 973 Ford DM, Briscoe DM, Shanley PF, Lum GM: ChildFan WW See K!eppe! MM et al 1629 hood membranoproliferative g!omerulonephritis type Fanelli V (abst) I: Limited steroid therapy 1606 1447 Fanti P (abst) 697 486 Fornasieri A (abst) Farhood A See Truong LD et al 1676 Forneris G (abst) 1442 Faronato PP See Fioretto P et a! 813 Forsberg A-M See Canepa A et a! 1016 Fauchald P (abst) 507 Forsiund T (abst) 505 496 Foster MH (abst) Faugere MC (abst) 695 Fawdry RM See Nankivell BJ et a! 450 Foster MH See Vlahakos DV et at 1690 Fedeli L (abst) 1440 Fou!ks Ci See Levy FL et a! 961 Federlin K (abst) 479 Fouqueray B See Baud L et al 600 Fehrman I (abst) 505 Franco V (abst) 1441 1438 Frandsen H (abst) Feingold KR (abst) 505 Feith GW (abst) 1430 Frank J (abst) 482 Fellin G (abst) 697, 1446 Frank JA See Choyke PL et al 1595 FellstrOm B (abst) 501, 512 Fransen R (abst) 1430 Fenton S See Pei Y et al 1374 Franz HE (abst) 483, 486, 492, 494, 495, 495 Feriani M See Ronco C et al 1383 Frattola A See Parati G et a! 37:S-24 Fernández JM, Carbonell ME, Mazzuchi N, Petruccelli Fredin DM See Takeda M et a! 1713 D: Simultaneous analysis of morbidity and mortality Frei U (abst) 481, 486, 487 factors in chronic hemodialysis patients 1029 Frenken LAM, Wetzels JFM, Sluiter HE, Koene RAP: Ferrari P (abst) 481 Evidence for renal vasodilation in pre-dialysis Ferrari P See Blumberg A et a! 369 patients during correction of anemia by 384 1446 Ferrari S (abst) erythropoietin 420 Ferrario F (abst) 1447, 1447 Frey BM See Schaad HJ et a! 420 37:S-97 Frey Fi See Schaad Hi et al Ferraro T See Tarjan E et al

1756

Author Index: Vol. 41

Freyss-Beguin MM, Brussel EMM-V, Simon JM, Duval DP: Regulation of membrane phospholipid metabolism in heart cell culture 37:S-79 505, 505, 505 Friedberg M (abst) 983 Friedlander G See Vrtovsnik F et a! 877 Friedman R See Lopes de Faria JB et a! 488 Friedrich F (abst) Fries JWU, Collins T: Platelet-derived growth factor 584 expression in a transgenic model Frisenette-Fich C (abst) 504, 506 1444 Frisina N (abst) 479 Fritsch G (abst) FrØland A See Damsgaard EM et al 731 Frolich JC See Radermacher J et al 1549 510 Frost L (abst) 805 Frystyk J See Flyvbjerg A et a! 951 Fuiano G See Canton AD et al 65 Fulpius T See Lemoine R et al Funder JW: Enzymes and the regulation of sodium 37:S-114 balance 482 FunfstUck R (abst) Furthmayr H, Lankes W, Amieva M: Moesin, a new cytoskeletal protein and constituent of filopodia: Its 665 role in cellular functions Fusaroli M (abst) 1442, 1442 350 Fushimi K See Sakamoto H et al 505 Fyhrquist F (abst) Gabbiani G: The biology of myofibroblasts 530 37:S-87 Gabbiani G See Desmoulière A et a! Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomal-domi1311 nant polycystic kidney disease Gafter U, Kalechman Y, Sredni B: Induction of a subpopulation of suppressor cells by a single blood 143 transfusion 486 Gahi GM (abst) 486 Galette A (abst) 758 Gall M-A See Parving H-H et al 706 Gallatin M (abst) 1443 Galli F (abst) 1443 Gallieni M (abst) 1701 Gambertoglio JG See A!-Uzri A et al 1447 Ganadu M (abst) Gandini E (abst) 1445, 1447, 1447 497 GaBner B (abst) Ganten D (abst) 478, 496, 496 24 Ganten D See Bachman S et a! 1468 Gariboglu S (abst) 1446 Garibotto G (abst) Garlick PJ See Bailmer PE et a! 132 1059 Gaskin G See Spencer SJW et a! Gaspari F, Mosconi L, ViganO G, Perico N, Torre L, Virotta G, Bertocchi C, Remuzzi G, Ruggenenti P: Measurement of GFR with a single intravenous injection of nonradioactive iotha!amate 1081 (Technical Note) Gattone VH II See Harding MA et al 317 Gavin JB See Miller TE et a! 1356 Gawaz MP (abst) 482 Geatti 0 (abst) 1443 Geberth S (abst) 498 Gedik Y (abst) 1471 Geiger H (abst) 482 Geissinger B See Olbricht CJ et al 966 Gentile MG (abst) 1446

705 Gerbitz KD (abst) 1445 Gherardi G (abst) 1439 Ghio L (abst) 1439 Giacchino F (abst) 1439 Giani M (abst) 1560 Gibbons N See Singhal PC et al 697 Gibelli A (abst) Gibson 1W, Downie I, Downie TT, Han SW, More JAR, Lindop GBM: The parietal podocyte: A study of the vascular pole of the human glomerulus (Tech211 nical Note) 491 Giefielmann S (abst) 698 Gila JA (abst) 489 Gilbert P (abst) Gilli P (abst) 1441, 1443 924 Gil!ingham KJ See Cheung AHS et al 1676 Gillum D See Truong LD et at Giordano A (abst) 1447, 1447 1443 Giordano F (abst) Girard A See Cloarec-Blanchard L et al 37:S-14 481 Girchev R (abst) 1595 Girton ME See Choyke PL et al 1445 Giucastro G (abst) Giudicelli J-F See Berdeaux A et al 37:S-29 1443 Giura C (abst) Gladziwa U (abst) 482, 483, 493, 1434 Gladziwa U See Kooman JP et al 1041 Glassock RJ (abst) 700, 705 768 Glas sock RJ See Ihm C-G et al 507 Goch J (abst) 485 Gogelein H (abst)

Gogu S (abst) Gôkce c (abst) Gokce 0 (abst)

1470

1469 1469

706 Goldberg H (abst) Goldfarb S See Rocco MV et at 107 1431 Goldschmeding R (abst) Goldsmith DJA, Hilton PJ: Relationship between intracellular proton buffering capacity and 43 intracellular pH 1468, 1470 Gonenc F (abst) Gonick HC See Khalil-Manesh F et al 1192 Goodman S See von der Mark K et a! 632 Goodman SL: a6/3l integrin and laminin E8: An in650 creasingly complex simple story Gordon K See Floege J et al 297 Gosselink MAHE (abst) 1437 478 Gotze M (abst) Gould YE See Korhonen M et al 641 Gove C See Moore KP et al 1543 Gown AM See Alpers CE et al 1134 Grabensee B (abst) 485, 487 699 Grabowski P (abst) Grant M See Neufeld TK et al 1222 317 Grantham JJ See Harding MA et a! Grantham JJ See Neufeld TK et al 1222 Grassi C (abst) 1443 Grayburn PA See Levy FL et a! 961 Graziani G (abst) 1446 Greca GL See Ronco C et a! 1383 Green DF, Hwang KH, Ryan US, Bourgoignie JJ: Cu!ture of endothelial cells from baboon and human glomeruli 1506 Green DF, Resnick L, Bourgoignie JJ: HIV infects gbmerular endothelial and mesangia! but not epithelial cells in vitro 956

Author Index: Vol. 41

1757

Greenwood C See Pei Y et al 1374 Han HS (abst) 1461 Greven J (abst) 478, 479 Han iS (abst) 1453, 1454 Grond J (abst) 702, 1431, 1432 Han SW See Gibson 1W et a! 211 Grond J See Wolthuis A et a! 124 Hanatani M (abst) 484 Gronhagen-Riska C (abst) 1340 499, 503, 508 Handt S See Ittel TH et al Grootendorst AF (abst) 1434 Hanna JD See Santos F et al 356 Gross P(abst) 485 Hannemann J (abst) 484 Grosser S (abst) 480 Hänsch GM (abst) 486, 496 Grover PK, Ryall RL, Marshall VR: Calcium oxalate Hansen FM (abst) 508 crystallization in urine: Role of urate and Hansen HE (abst) 502, 508, 510 149 Hansen KW, Christensen CK, Anderson PH, Pederson glycosaminoglycans Groves BM See Hensen J et al 1333 MM, Christiansen iS, Mogensen CE: Ambulatory Gruber E See Ittel TH et a! 1340 blood pressure in microalbuminuric type 1 diabetic Grune T (abst) 494 847 patients Grunewald JM (abst) 483 Hansen KW See Flyvbjerg A et a! 805 Grunewald RW (abst) 483, 492 Hansen KW See Pederson MM et a! 883 GrUnfeld i-P See Cloarec-Blanchard L et al 37:S-14 Hansen SI See Hoim J et al 50 Grunicke H (abst) 488 Hansen-Schmidt S (abst) 492 1456 Hanssen KF (abst) Grupe WE (abst) 703 494 Hanssen KF See Dahl-JØrgensen K et at Grupp C (abst) 920 483 Hara M See Ohashi K et al Grupp CT (abst) 1646 GrUtzmacher P (abst) 496 Haraldsson BS, iohnsson EKA, Rippe B: Glomerular Grzeszczak W (abst) 488 permselectivity is dependent on adequate serum conGuarena C (abst) centrations of orosomucoid 1442, 1442 310 Gudat F (abst) 1445 Harding MA, Gattone VH II, Grantham ii, Calvet JP: Guerra L (abst) 1439 Localization of overexposed c-myc mRNA in polyGuignard J-P See Pedrotti A et al 80 cystic kidneys of the cpk mouse 317 Guillermo R (abst) 700 Hardlund i (abst) 501 Guillermo R See Ihm C-G et a! 768 Harendza S (abst) 491 Gulbins E (abst) 492 Harlow JE See Tilton RG et al 778 GüilU M (abst) 1468 Harman N (abst) 1472 Gülliilü M (abst) 1466 Harrer U See Erley CM et a! 1297 1468 Harris AG See Flyvbjerg A et a! Gultepe M (abst) 805 1470 Harris DCH See Nankivell Bi et a! GOne Z (abst) 450 Hartman A (abst) Gupta S, Rifici V, Crowley S, Brownlee M, Shan Z, 703 Schiondorif D: Interactions of LDL and modified 1472, 1473 Hasanoglu E (abst) LDL with mesangial cells and matrix 1161 Haslett C (abst) 704 Gurland Hi (abst) 482 Hasslacher C (abst) 484 Gusmano R See Canepa A et al 1016 Haugen OA (abst) 500 Gutjahr E See Olbricht Ci et a! 966 Hauser IA (abst) 702 Gyotoku Y See Lemoine R et al 65 Haussinger D (abst) 496 Ha C-Y (abst) 1448 Haverty TP See Alvarez Ri et al 14 Ha SK (abst) 1448, 1456, 1462 Havu N See Nordlander M et a! 36:S-100 Haas C (abst) 483 Hawk CT See Schafer JA et al 255 Haberstroh U (abst) 483, 495, 696 Hayashi H, Karasawa R, Inn H, Saitou T, Ueno M, Hack CE (abst) 1431, 1438 Nishi S, Suzuki Y, Ogino 5, Maruyama Y, Kouda Y, 1433 Hackeng WHL (abst) Arakawa M: An electron microscopic study of gbHackenthal E See Sakai T et a! 533 meruli in Japanese patients with non-insulin depenHacki A (abst) 484 dent diabetes mellitus 749 Hah JO (abst) 1465 Hayes C See Yanagisawa H et a! 1000 Haist K (abst) 495 Hayry P See Isoniemi HM et ai 155 Haites NE (abst) 699, 703, 706 Haznedar R (abst) 1472 Hakim R See Himmelfarb J et al 388 Hdersdal C (abst) 505, 506 Halbhuber K-i (abst) 482 He Ci, Kanfer A: Quantification and modulation of 500 Halgunset i (abst) thrombomodulin activity in isolated rat and human Hailer H (abst) 484, 484, 696 1170 glomeruli Hallmann R (abst) 696 Head GA: Central monoamine neurons and cardiovasHalse J (abst) 509 cular control 37:S-8 Hamamizade NM (abst) 1472 Hebert CL See Nahman NS Jr. et al 396 Hamm LL See Bonilla-Felix M et a! 1150 Heeger P, Wolf G, Meyers C, Sun MJ, O'Farrell SC, Hammer M (abst) Krensky AM, Neilson EG: Isolation and characteri508, 508 Hammond WS See Almeida ARP et at 1494 zation of cDNA from renal tubular epithelium encoding murine Rantes 220 494 Hampl H (abst) 1274 414 Hefferton D See Barrett Bi et a! Hamzeh Y See Said R et al 495 Han DC(abst) 1455, 1458, 1459, 1459 Heidenreich S (abst) 482, 704 Heidland A (abst) Han DS (abst) 1448, 1456, 1458, 1459, 1462, 1463, 1463

1758

Author Index: Vol. 41

492 Heimburger 0, Waniewski J, Werynski A, Liodhoim B: Hoppe A (abst) A quantitative description of solute and fluid trans496 Hoppe D (abst) 1320 }-Iörkkö S, Savolainen MJ, Kervinen K, Kesäniemi YA: port during peritoneal dialysis Heinrichs A See Ittel TH et al 1340 Carbamylation-induced alterations in low-density 706 Helaakoski T(abst) 1175 lipoprotein metabolism Heldin C-H, Ostman A, Eriksson A, Siegbahn A, ClaesHorl WH (abst) 479 son-Welsh L, Westermark B: Platelet-derived growth Horvei G See Ofstad J et al 36:S-8 factor: Isoform-specific signaling via heterodimeric or Hostetter TH See Correa-Rotter R et al 796 571 homodimeric receptor complexes Hostetter TH See Correa-Rotter R et al 938 Hellings SE See Takeda M et al 1713 Hostetter TH See Salahudeen AK et a! 183 Helmchen U (abst) 485, 497 Houhou S See Cloarec-Blanchard L et a! 37:S-l4 Hennerkes B See Minuth WW et al 215 Houillier P, Borensztein P, Bichara M, Paillard M, PriHenrich WL See Levy FL et a! 961 gent A: Chronic neutral phosphate supplementation Hensen J, Abraham WT, Lesneefsky EJ, Levenson B, induces sustained, renal metabolic alkalosis 1182 Groves BM, Schroder K, Schrier RW, DUrr J: Atrial 485 Hoyer T (abst) natriuretic peptide kinetic studies in patients with car704 Huang S (abst) 1333 diac dysfunction Hudkins KL See Alpers CE et a! 1134 Hercz G See Pei Y et al 1374 1448 Herlitz H (abst) 510 Huh KB (abst) Huitema S (abst) 1432 Herlitz H: Long-term effects of felodipine in patients Humphries MJ: Peptide recognition motifs involved in with reduced renal function 36:S-110 the binding of integrins to their ligands 645 Hermle M (abst) 498 498 Hupp T (abst) Hermie M See Bock HA et a! 275 490 Hernando L (abst) 695 Huwiler A (abst) Herndon J See Bonilla-Felix M et a! 1150 Huysmans FTM, van Hamersvelt HW, Sluiter HE, Wetzels JFM, Koene RAP: Acute renal effects of 494 Herzog R (abst) felodipine in hypertensive patients with kidney Heublein DM See Ciresi DL et al 1599 disease 36:S-106 Hiatt WR, Koziol BJ, Shapiro TI, Brass EP: Carnitine Huysmans FTM See van Hamersvelt HW et al 36:S-73 metabolism during exercise in patients on chronic Hwang KH See Green DF et at 1506 1613 hemodialysis 1455, 1458, 1459, 1459 Hildebrandt F (abst) 485 Hwang SD (abst) 1449 Hill GS See Quan Zy et al 326 Hwang Y (abst) 503, 504 Hill RD See Messent JWC et at 836 Hylander B (abst) 1366 Hilton PT See Goldsmith DJA et a! 43 Hyver SW See Pallone TL et a! Ido Y, Tilton RG, Chang K, Pugliese G, Williamson Himmelfarb J, Zaoui P, Hakim R, Holbrook D: ModuJR: Rapid measurement of glomerular filtration rate lation of granulocyte LAM-i and MAC-i during dialin small animals (Technical Note) 435 388 ysis—A prospective, randomized controlled trial 485 Ho YD (abst) 1456 Igarashi P (abst) Hocher B (abst) 485 Ihm CG (abst) .... 700, 702, 1449, 1449, 1452, 1454, 1456, 1462 Hoedemaeker PhJ (abst) 1430 Ihm C-G, Lee GSL, Nast CC, Artishevsky A, Guil!ermo R, Levin PS, Glassock RJ, Adler SG: Early Hoedemaeker PT (abst) 700 increased renal procallogen ai(IV) mRNA levels in Hoedemaeker PT See Bruijn TA et al 5 streptozotocin induced diabetes 768 Hoefliger N See Vanholder R et al 1707 Hoffstedt E (abst) 506 lida H See Johnson R et a! 590 1469 Hofstädter F See Ittel TH et a! 1340 Ilhan N (abst) 704 Imai H See Komatsuda A et al 1204 Hogg N (abst) Hogg N, Bennett R, Cabanas C, Dransfield I: LeukoImbasciati E (abst) 1445 613 Imholz ALT (abst) 1436 cyte integrin activation HØier-Madsen M See HoIm T et al 50 Inagami T See Takeda M et al 1713 Holbrook D See Himmelfarb J et a! 388 Ingerslev T (abst) 502 Holdaas H (abst) 507 Inn H See Hayashi H et a! 749 Hollenbeck M (abst) 485 lozzo RV See Alvarez RJ et a! 14 Holliday MA See Al-Uzri A et al 1701 1467 Ipek Cingi M (abst) HoIm J, Hansen SI, HØier-Madsen M, Bostad L: A 485 Irzyniec T (abst) 1470 high-affinity folate binding protein in proximal tubule Iimer A (abst) cells of human kidney 50 Islam S See Nutting CW et a! 166 Hoistein-Rathlou NH (abst) 508 Isoniemi HM, Krogerus L, van Willebrand F, Taskinen HolthOfer H (abst) 696 E, Ahonen J, Hayry P: Histopathological findings in Homma T See Takeda M et a! 1713 155 well-functioning, long-term renal allografts Hommel E See Borch-Johnsen K et al 719 Itoh H See Komatsuda A et al 1204 Honda K See Ohashi K est a! 1646 Ittel TH, Gruber E, Heinrichs A, Handt S, Hofstädter Hong CD (abst) 1450, 1458 F, Sieberth H-G: Effect of fluoride on aluminum-inHong SP (abst) 1450 duced bone disease in rats with renal failure 1340 Honkanen E (abst) 499, 503, 508 Iversen BM See Ofstad J et a! 36:S-8 Hoover RL See Takeda M et al 1713 Izui S See Lemoine R et a! 65 Hopfenmuller B (abst) 486 Jacobsen BA (abst) 511

Author Index: Vol. 41

Jaffa AA, Chai KX, Chao J, Chao L, Mayfield RK: Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney 789 Jahn B (abst) 486, 496 Jandhyala BS See Chintala MS et al 36:S-94 1463 Jang TJ (abst) Janssen WMI See de Zeeuw D et a! 1115 Jarrett RJ See Messent JWC et a! 836 Jayne DRW See Esnault VLM et al 1304 Jenkins DAS (abst) 699 Jennette JC See Ewert BH et a! 375 Jennings GL See Angus JA et a! 37:S-73 Jensen C (abst) 503 Jensen G (abst) 512 Jensen JS See Borch-Johnsen K et a! 719 Jensen LT (abst) 501, 502, 503 1453 Jeong HJ (abst) Jeong MS (abst) 1448, 1451 Jeppesen L (abst) 505, 506 510 Jeppsson J-O (abst) Jerums G, Allen T, Tsa!amandris C, Cooper ME: Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic 904 nephropathy Jerums 6 See Cooper ME et a! 898 Joffe P (abst) 503, 503, 503 504 Jogestrand T (abst) Johansson A-C (abst) 504 Johnsen SA (abst) 512 Johnson AM See Gabow PA et al 1311 Johnson R, lida H, Yoshimura A, Floege J, BowenPope DE: Platelet-derived growth factor: A poten590 tially important cytokine in glomerular disease Johnson RJ (abst) 701 Johnson RJ See Alpers CE et al 1134 Johnson RJ See Floege J et al 297 Johnsson EKA See Haraldsson BS et a! 310 Johnston CI See Luft FC et al 36:S-114 Joles JA (abst) 1438 Jones C(abst) 701 Jones H (abst) 1438 Jones JM See Simon son MS et a! 542 Jones MC (abst) 703 Jones RH See Gabow PA et a! 1311 Jones SL, Kontessis P, Wiseman M, Dodds R, Bognetti E, Pinto J, Viberti G: Protein intake and blood glucose as modulators of GFR in hyperfiltering diabetic 1620 patients Jones SL See Walker JD et al 741

JongPESeedeZeeuwDetal JØrgensen AF (abst) JØrgensen F See Parving H-H et a! JØrgensen HE See Parving H-H et a! JØrgensen OD See Damsgaard EM et a! JOnes A (abst) JØrstad S (abst)

Jover B See Mimran A et al Julien C See Barrès C et al Jungmann E (abst) Jutila MA (abst) Kaehny WD See Gabow PA et a! Kagami S See Border WA et al Kâgedal B (abst) Kahi A (abst) Kala A-R (abst) Kalechman Y See Gafter U et al

Kallenberg CGM (abst) Kamper AL (abst) Kampf D (abst) Kämpf W (abst) Kanfer A See He CJ et al Kang CM (abst)

KangFT(abst)

1759 1435

499, 508 486 492 1170

1449, 1460, 1465 1455, 1455

1449 Kang KW (abst) 1453 Kang SH (abst) 1448 Kang S-K (abst) 1451 Kang YJ (abst) Kanwar YS See Watanabe Y et al 1262 Kaplan R See Wilkes BM et a! 992 Kapoor V See Arnolda L et al 37:S-2 1467 Karakullukçu F (abst) 1473 Karaoglan U (abst) Karasawa R See Hayashi H et al 749 Karatan 0 (abst) 1469 706 Karsenty G (abst) Kashgarian M, Sterze! RB: The pathobiology of the 524 mesangium Kashihara N See Watanabe Y et a! 1262 Kashtan CE See Kleppel MM et a! 1629 Katholi RE See Barfuss DW et al 1143 Katinios A See Magoula I et a! 1349 Kato T See Takahashi K et a! 1245 Katz M See Viahakos DV et a! 1690 Kavak!i K (abst) 1467 Kawai R See Ohashi K et a! 1646 Kawasaki K, Yaoita E, Yamamoto T, Kihara I: Depletion of CD8 positive cells in nephrotoxic serum nephritis of WKY rats 1517 1467 Kaygisiz Z (abst) 1438 Kaysen GA (abst) Keck I (abst) 489 Keen H See Messent JWC et a! 836 Keen H See Walker JD et al 741 Keller F (abst) 485 Kemmer FW (abst) 485, 487 Kent G See Barrett BJ et al 1274 Keogan MT See Esnault VLM et a! 1304 Kerjaschki D: Molecular pathogenesis of membranous 1090 nephropathy (Nephro!ogy Forum) Kerr PG, Argues A, Flavier J-L, Canaud B, Mion CM: Comparison of hemodialysis and hemodiafi!tration: A 1035 long-term longitudinal study Kervinen K See HOrkkO S et a! 1175 Kesäniemi YA See HOrkkO S et a! 1175 Kesteloot D (abst) 1432 1115 Khalil-Manesh F, Gonick HC, Cohen AH, Alinovi R, 510 Bergamaschi E, Mutti A, Rosen VJ: Experimental 758 model of lead nephropathy. I. Continuous high-dose 758 lead administration 1192 731 1460 Khang KW (abst) 486 Kielstein R (abst) 488 507 Kienle S (abst) 495, 495 37:S- 107 Kiersztejn M See Chervu I et a! 1501 37:S-19 Kieruif P See Dahl-JØrgensen K et a! 920 486, 492 Kihara I See Kawasaki K et al 1517 696 Kilburg M (abst) 491 1311 1473 Kilicturgay S (abst) 566 Killen PD (abst) 706 510 Kim BU (abst) 1464 486 Kim CH (abst) 1455 503 Kim CY (abst) 1462 143 Kim FS (abst) 1455

1760

Kim G-H (abst) Kim HC (abst) Kim HJ (abst) Kim HK (abst) Kim HS (abst) Kim JC (abst) Kim JS (abst) Kim JW (abst) Kim KR (abst) Kim KS (abst) Kim KY (abst) Kim MC (abst) Kim MJ (abst) Kim MK (abst) Kim MS (abst) Kim P (abst) Kim S (abst) Kim SB (abst) Kim SH (abst) Kim SY (abst) Kim WI (abst) Kim WJ (abst) Kim WM (abst) Kim Y (abst) Kim YG (abst) Kim Yl (abst) Kim YK (abst)

Author Index: Vol. 41

1454, 1455 1453, 1456, 1458, 1460 1450, 1450, 1451, 1457, 1463 1452,

1457 1449 1456 1451

1456 1463 1461

1449, 1449, 1452,

1453,

1454, 1456, 1462, 1462 1457 1457 1453

1453, 1454, 1460 1450, 1458 1457, 1462 1448, 1455, 1457, 1464, 1464 1464 1450 1457

704, 1454 1453, 1461 1453, 1460

1448, 1448, 1456, 1458, 1459, 1462,

Kim YS (abst)

1455, 1459

1448, 1456, 1459, 1463, 1463

1463, 1463

1448, 1455, 1455, 1457, 1460, 1460, 1464, 1464, 1465

Kimberling WJ

See Gabow PA et a! 1311 GL See Nayak RC et a! 1638 Kinne R (abst) 1444 Kinne RKH (abst) 483 Kirazli S (abst) 1471, 1472 Kirchheim HR (abst) 481, 490 Kirste T (abst) 698 Klahr S See Reyes AA et a! 100 Klahr S See Reyes AA et at 403 Klahr S See Yanagisawa H et al 1000 Kianke B See Radermacher J et al 1549 Klar N (abst) 1435 Klein J (abst) 486 Kleinknecht D See Ma! F et a! 445 704 Kieppel M (abst) Kleppel MM, Fan WW, Cheong HI, Kashtan CE, Michael AF: Immunochemical studies of the Alport 1629 antigen Kliem V (abst) 486, 487 482, 487 K!inger M (abst) Kioth S See Minuth WW et al 215 Kiotman PE See Smith SR et at 199 Klotz U (abst) 482 Knoers VVAM (abst) 1430 Knudsen F (abst) 502 Knudsen L (abst) 502 Ko CW (abst) 1450 Ko KW (abst) 1453, 1454, 1461 King

Kocak H (abst) Kocak N (abst) Koch KM (abst) Koch KM: Dialysis-related

Forum) Koch M (abst) Koene RAP (abst)

1468 1466, 1467, 1473

481

amyloidosis (Nephrology 1416

487, 701 1430

Koene RAP See Frenken LAM et al 384 Koene RAP See Huysmans FTM et al 36:S-106 Koene RAP See van Hamersvelt 11W et al 36:S-73 Koenig KG, Lindberg JS, Zerwekh JE, Padalino PK, Cushner HM, Copley JB: Free and total 1,25dihydroxyvitamin D levels in subjects with renal disease 161 Koeser T (abst) 487 Kofoed-Enevoidsen A: Inhibition of glomerular glucosaminyl N-deacetylase in diabetic rats 763 Kogan BA See Al-Uzri A et at 1701 Koh YB (abst) 1460, 1464, 1464 Köhler H (abst) 487 Kokot F (abst) 488 KOIIer M (abst) 496, 496 500 Kolmannskog F (abst) Komatsuda A, Wakui H, Imai H, Nakamoto Y, Miura AB, Itoh H, Tashima Y: Rena! localization of the constitutive 73-kDa heat-shock protein in normal and PAN rats 1204 Kon V See Takeda M et al 1713 Konieczkowski M See Sedor JR et al 595 Kontessis P See Jones SL et al 1620 Koo JH (abst) 1450 Koo WS (abst) 1448, 1455, 1457, 1464, 1464, 1465 Kool M (abst) 1433 Kooman JP (abst) 1434, 1435 Kooman JP, Wijnen JAG, Draaijer P, van Bortel LMAB, Gladziwa U, Peltenburg HG, Struyker-Boudier HAJ, van Hooff JP, Leunissen KML: Compliance and reactivity of the peripheral venous system in chronic intermittent hemodialysis 1041 Koomans HA (abst) 1430, 1434, 1435, 1436 Koomen GCM (abst) 1436, 1437, 1437 Koomen GCM See Struijk DG et a! 1668 1437, 1437 Koopman MG (abst)

Kope W (abst)

487

Kopp JB, Bianco P, Young MF, Termine JD, Robey PG: Renal tubular epithelial cells express osteonectin in vivo and in vitro 56 1469 Koray Z (abst) Korhonen M, Laitinen L, Ylänne J, Gould YE, Virtanen I: Integrins in developing, normal and malignant 641 human kidney Korner PT, Bobik A, Angus JA: Are cardiac and vascular "amplifiers" both necessary for the development 37:S-38 of hypertension9 Korner P1 See Angus JA et at 37:S-73 Koruk M (abst) 1472 1434 Koster HPG (abst) Köster W (abst) 479 Kouda Y See Hayashi H et a! 749 Kouw PM, Olthof CG, ter Wee PM, Oe LP, Donker AJM, Schneider H, de Yries PMJM: Assessment of post-dialysis dry weight: An application of the con440 ductivity measurement method (Technical Note) Koziol BJ See Hiatt WR et a! 1613 Kozma V (abst) 511 508 Kragballe K (abst) Kramarz S (abst) 487 Kramer BK See Erley CM et a! 1297 Kramer HJ, Meyer-Lehnert H, Mohaupt M: Role of calcium in the progression of renal disease: Experimental evidence 36:S-2 Krause R (abst) 488 Krediet RT (abst) 1433, 1436, 1437

Author Index: Vol. 41

Krediet RT See Struijk DG et a! Kreisberg JI (abst) Krensky AM See Heeger P et a! Krieg RJ See Santos F et a! Kristensen JK (abst) Kriz W (abst) Kriz W See Sakai T et al Krogerus L See Isoniemi HM et a! Krogsgaard K (abst) Krol MC (abst) Krolewski AS See Barzilay J et a! Krzymañski M (abst) Kuch R (abst) Kuchta G (abst)

1668

700 220 356 509

478, 481, 489, 696 533 155

502 695 723

488 488 492

KUhn B (abst) KUhn R (abst)

482 482

Kuhn W (abst)

489 575 695

Kumjian DA See Daniel TO et a! Kunkel SL (abst) Kunkel SL See Schmouder RL et al Kunzendorf U See Neumayer H-H et a! Kurkus J (abst) Kurnik BRC See Weisberg LS et a! Kurnik PB See Weisberg LS et al Kurtz A (abst) Küster S (abst) KUtUkçUIer N (abst) KUtUkç!üler N (abst)

191

36:S-87 509 1408 1408

481, 493 488 1467 1468

Kvam Fl See Ofstad J et al 36:S-8 Kwak KC (abst) 1455, 1455 Kwon HM (abst) 1459 Kwon HS (abst) 1451 Kwon TH (abst) 1457, 1462 Kwon YJ (abst) 1452, 1455, 1459 1444 La Milia V (abst) 455 Laborde K See Shahedi M et a! 37:S-67 Lacape G See Ramboer I et al 505, 508 Ladefoged S (abst) 502, 503, 505, 508 Ladefoged SD (abst) 723 Laffel LMB See Barzilay J et a! 891 Lafferty HM See Anderson S et a! 641 Laitinen L See Korhonen M et a! 281 Lajeunesse D See Brunette MG et a! 289 Lajeunesse D See Brunette MG et al 37:S-67 Lamaziere J-MD See Ramboer I et al 1430 Lambers A (abst) 1292 Lambert MB See Collins DM et al 1433 Lamberts LV (abst) 1400 Lamberts LV See Vasilakakis DM et al 1432 Lameire N (abst) 1443 Lamperi D (abst) Lane PH, Steffes MW, Mauer SM: Estimation of gbmerular volume: A comparison of four methods 1085 (Technical Note) 488, 496 Lang F (abst) 483 Langhans S (abst) 665 Lankes W See Furthmayr H et al Larochelle P: Renal tubular effects of calcium 36:S-49 antagonists 37:S-67 Larrue J See Ramboer I et al 758 Larsen S See Parving H-H et al 507 Larsson K (abst) 478 Laske V (abst) 502 Lassen A (abst) 489 Lauchert W (abst) 1286 Laurent G See Charra B et a!

1761

Lausten GS (abst) 508 Lavarda F (abst) 1445 Law N (abst) 697 Lax DS, Benstein JA, Tolbert E, Dworkin LD: Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys 1527 Le Grimellec C See Vrtovsnik F et al 983 Leclercq C See Beuve CS et a! 37:S-45 LeDuc J (abst) 1431 Lee BJ (abst) 1455 Lee C-E (abst) 1453 Lee DK (abst) 1458 Lee GSL (abst) 700 Lee GSL See Ihm C-G et al 768 Lee HB (abst) 1455, 1458, 1459, 1459 Lee HC (abst) 1448 Lee HS (abst) 1453, 1460 Lee HW (abst) 1431 Lee HY(abst) 1448, 1451, 1456, 1458, 1459, 1462, 1463, 1463

Lee IH (abst) 1465 1451 Lee J (abst) Lee JD (abst) 1464 1449 Lee JJ (abst) Lee JK (abst) 1453 Lee JS (abst) 1453, 1453, 1454, 1460 1462 Lee JT (abst) Lee JY (abst) 1451, 1451 1462 Lee KB (abst) 1463 Lee KK(abst) 1450 Lee KU (abst) 1460 Lee KY (abst) 478 Lee MA (abst) 1450 Lee MH (abst) 1458 Lee SG (abst) 1461 Lee SH (abst) Lee SK (abst) 1452, 1458, 1459, 1459 1457, 1461, 1461 Lee SR(abst) 1452 Lee SY (abst) Lee TW (abst) 1449, 1449, 1452, 1454, 1456, 1462 1450, 1452 Lee YC (abst) 1458 Lee YS (abst) 100 Lefkowith J See Reyes AA et a! 503 Lehmann H (abst) 455 Lelongt B See Shahedi M et a! 1432 Lemkes HHPJ (abst) 533 Lemley KV See Sakai T et al Lemoine R, Berney T, Shibata T, Fulpius T, Gyotoku Y, Shimada H, Sawada 5, Izui 5: Induction of "wireloop" lesions by murine monoclonal IgG3 65 cryoglobulins 1433 Lemoniatou E (abst) 1400 Lemoniatou E See Vasilakakis DM et al 490 Lempinen M (abst) 1443 Leonardis D (abst) 396 Leonhart KL See Nahman NS Jr. et a! 1333 Lesneefsky EJ See Hensen J et al Leunissen KML (abst) 1433, 1434, 1435 1041 Leunissen KML See Kooman JP et a! 1333 Levenson B See Hensen J et al Lever AF, Lyall F, Morton JJ, Folkow B: Angiotensin 37:S-5 1 II, vascular structure and blood pressure 768 Levin PS See Ihm C-G et a! Levy FL, Grayburn PA, Foulks CJ, Brickner ME, Henrich WL: Improved left ventricular contractility 961 with cool temperature hemodialysis

1762

Author Index. Vol. 41

499, 508 Leyssac PP (abst) Lezotte DC See Gabow PA et al 1311 Libetta C (abst) 1445 Lillevold PE (abst) 500 Urn CS (abst) 1460 Lirn HE (abst) 1462 Urn IS (abst) 1452 Lim TH (abst) 1458 Urn VS See Syrnreng T et a! 1064 Lin J-T See Rassier ME et al 88 Linari F (abst) 1445 Lindberg iS See Koenig KG et al 161 506 Lindberger K (abst) Linde T (abst) 506, 509 Lindell A (abst) 510 509 Lindergârd B (abst) 510 Lindgren S (abst) Lindh E (abst) 507 Lindholm A (abst) 505 Lindholrn B See Heimburger 0 et a! 1320 Lindner G (abst) 1441 Lindop GBM See Gibson 1W eta! 211 511 Lindqvist B (abst) Lindschau C (abst) 484, 696 512 Lindsjö M (abst) Lindström H (abst) 507 Linné T (abst) 499 Lins L-E (abst) 504 Liu E (abst) 701 507 Ljunghall S (abst) L1ewe11yn-Smith I See Arnolda L et al 37:S-2 Lloyd MA See Ciresi DL et al 1599 Locatelli F (abst) 1444 Lockwood CM See Esnault VLM et a! 1304 Lodde P (abst) 1447 Logue B See May RC et a! 1535 LØkkegaard H (abst) 505, 513 LØkkegaard H See Parving H-H et a! 758 LØkkegaard N (abst) 502 Lonnemann G (abst) 481 Lopes de Faria JB, Friedrnan R, Tariq T, Viberti GC: Prevalence of raised sodium-lithiurn conntertransport activity in type I diabetic patients 877 LOpez-Farre A (abst) 695 Lorbeer B (abst) 483 Lovett DH See Davies M et a! 671 Lubrich-Birkner I (abst) 489 Luff SE See McLachlan EM et a! 37:S-56 Luft FC, Johnston CI: Are calcium antagonists of value in ameliorating the course of chronic renal disease9 36:S-l14 Lurn GM See Ford DM et al 1606 Lundberg L (abst) 511 Lundberg M (abst) 502 Lupi A See Ronco C et al 1383 Lusenti T (abst) 1441 Lusiani L See Trevjsan R et al 855 Lyall F See Lever AF et al 37:S-51 Machado IV See Muller GY et al 1055 Macica CM See Wilkes BM et al 992 Mackensen-Haen S (abst) 484 Macnicol AR See Watson ML et al 206 Madaio MP (abst) 695 Madaio MP See Viahakos DV et al 1690 Madri JA (abst) 702, 705

Madri JA, Marx M: Matrix composition, organization and soluble factors: Modulators of microvascular cell differentiation in vitro 560 Madri JA, Sterzel RB: Introduction 523 Magil AB See Wakai S et al 428 504 Magnusson M (abst) Magoula I, Tsapas G, Mavromatidis K, Katinios A: Single kidney function: Early and late changes in 1349 urate transport after nephrectomy Mailloux J See Brunette MG et al 281 Mailloux J See Brunette MG et a! 289 Majorca R (abst) 1440, 1440 Mak RHK: Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis 1049 patients Makjno H See Watanabe Y et al 1262 Ma! F, Meyrjer A, Callard P, Kleinknecht D, Altmann i-i, Beaugrand M: The diagnostic yield of transjugular renal biopsy. Experience in 200 cases (Technical 445 Note) Malfi B (abst) 1439 Mall G (abst) 485 Mallamaci F (abst) 1443, 1444 Mallick NP See Brenchley PE et a! 933 Malluche HH (abst) 486, 496 488 Maly K (abst) 484 Md!yusz M (abst) 484 Mályusz T (abst) Mancia G See Parati G et al 37:S-24 Mancini E (abst) 1446 Manivel JC See Correa-Rotter R et a! 938 Mann H (abst) 482, 483 Mann iS See DiBona GF et a! 36:S-1 Manna G (abst) 1446 Mans jer P See Beuve CS et a! 37:S-45 Manson Wi (abst) 1435 Mansour J See Berl T et a! 37 Mantero F See Fioretto P et al 813 Manuel A See Pei Y et a! 1374 Manzione A (abst) 1439 Marabini M (abst) 1446 Marangella M (abst) 1445 Marcussen N (abst) 499 Markovic-Lipkovski J (abst) 489, 489 Marshall SM See Flyvbjerg A et al 805 Marshall VR See Grover PK et a! 149 Martin D See Reyes AA et a! 403 Martin J See Davies M et a! 671 Martin LL See Smith SR et a! 199 Martinelli D (abst) 1443 Marurno F See Sakamoto H et a! 350 Maruyama Y See Hayashi H et a! 749 Marx M See Madri JA et a! 560 Mascher G (abst) 506 Maser E (abst) 479 Mason PJ (abst) 704 Massara C (abst) 1439 Massry SG See Chervu I et a! 1501 Masud T See May RC et a! 1535 Matas AJ See Cheung AHS et a! 924 Mathjesen ER See Borch-Johnsen K et a! 719 Mauer M, Mogensen CE, Viberti GC: Introduction 717 Mauer SM, Sutherland DER, Steffes MW: Relationship of systemic blood pressure to nephropathology in insulin-dependent diabetes mellitus 736 Mauer SM See Lane PH et a! 1085

Author Index: Vol. 41

Mauer SM See Vernier RL et a! 1070 Mavromatidis K See Magoula I et a! 1349 May RC, Masud T, Logue B, Bailey J, England B: Chronic metabolic acidosis accelerates whole body proteolysis and leucine oxidation in awake rats 1535 Mayfield RK See Jaffa AA et al 789 Mazzucco G (abst) 1447 Mazzuchi N See Fernández JM et a! 1029 McCann WP See Barfuss DW et al 1143 McCulloch L (abst) 701 McCune BK See Roberts AB et al 557 McDonald J See Barrett BJ et al 1274 McFarland H See Choyke PL et a! 1595 McHugh LE See Cheung AHS et al 924 McIntyre Si See Rassier ME et al 88 706 McKay N (abst) 703 McKay NG (abst) McKinley Mi: Common aspects of the cerebral regulation of thirst and renal sodium excretion 37:S-102 McLachlan EM, Luff SE: Sympathetic innervation of renal and extra-renal arterial vessels 37:S-56 McLeod AM (abst) 699 McManamon PJ See Barrett BJ et al 1274 McNurlan MA See Ballmer PE et a! 132 Medina J (abst) 698 Mehisen J (abst) 505, 506

MenèP(abst)

1442

Menè P, Pugliese F, D'Agostino A, Cinotti GA: Thromboxane A2, prostaglandins, and mesangial cell 554 proliferation Mento PF See Wilkes BM et al 992 Merlino C (abst) 1439 Merriweather C (abst) 490 Messent JWC, Elliott TG, Hill RD, iarrett R.J, Keen H, Viberti GC: Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty836 three year follow-up study Messineo L (abst) 1443 Metsärinne K (abst) 499 490 Meyer X (abst) Meyer-Lehnert H See Kramer HJ et al 36:S-2 Meyers C See Heeger P et al 220 Meyrier A See Mal F et al 445 Michael A (abst) 704 Michael AF See Kieppel MM et al 1629 Michel i-B See Anidjar S et a! 37:S-61 Michinaga I See Ogahara S et al 175 Middleton JP See Collins DM Ct al 1292 Miettinen A (abst) 696 Mihatsch Mi (abst) 483, 491, 495, 1445 Milan M See Ronco C et a! 1383 Miller D See Nakamura T et a! 1213 Miller LG See Choyke PL et al 1595 Miller TE, Findon G, Rainer SP, Gavin JB: The pathology of subclinical pyelonephritis—An experimental evaluation 1356 Mimran A, Ribstein i, Jover B: Aging and sodium homeostasis 37:S-107 Mimura N See Ohashi K et a! 1646 Mm L (abst) 697 Mm MG (abst) 1453 Minson i See Arnolda L et a! 37:S-2 Minuth WW, Dermietzel R, Kloth 5, Hennerkes B: A new method culturing renal cells under permanent superfusion and producing a luminal-basal medium 215 gradient (Technical Note)

1763

1445 Minutolo R (abst) 1035 Mion CM See Kerr PG et a! Mir S (abst) 1467, 1468, 1471 Mitchell KD See Carmines PK et a! 36:S-43 Mittermair C (abst) 698 Miura AB See Komatsuda A et al 1204 509 Mjornstedt L (abst) 1471 Mocan H (abst) 1439 Mocciaro A (abst) 731 Mogensen CE See Damsgaard EM et a! 847 Mogensen CE See Hansen KW et a! 717 Mogensen CE See Mauer M et a! Mogensen CE See Pederson MM et a! 883 36:S-2 Mohaupt M See Kramer HJ et al 1437 Molenaar iC (abst) Molitoris BA: The potential role of ischemia in renal 36:S-2! disease progression Moliz M (abst) 695 489 Moll R (abst) 1447 Monga G (abst) 1430 Monnens LAH (abst) 1445 Montanan A (abst) Moon C (abst) 1458, 1459, 1459 Moon CO (abst) 1450, 1450, 1451, 1457, 1463 1450 Moon DR (abst) 1461 Moon HR (abst) Moore KP, Taylor GW, Gove C, Wood J, Tan K-C, Eason J, Williams R: Synthesis and metabolism of the cysteinyl leukotrienes by the isolated pig 1543 kidney 1444 Morabito N (abst) More IAR See Gibson 1W et al 211 Morgan TO, Anderson A: Hemodynamic comparisons of enalapri! and felodipine and their combination .... 36:S-78 1446 Morganti A (abst) Moriero E (abst) 1443 697 Morigi M (abst) 1653 Morii H See Shoji T et a! 697 Morioka T (abst) MØrkrid L See Ofstad i et al 36:S-8 Moromisato R See Nayak RC et al 1638 1445 Morozumi K (abst) 1000 Morrissey i See Yanagisawa H et a! Morton JJ See Lever AF et a! 37:S-51 Moscatelli P (abst) 1446 Mosconi L See Gaspari F et a! 1081 487 Motz W (abst) 924 Moudry-Munns KC See Cheung AHS et a! Mukhtar A (abst) 703 MUller CA (abst) 489, 489 Muller GA (abst) 482, 489, 489, 495, 703 Muller GY, Zabaleta ME, Arminio A, Colmenares Ci, Capriles Fl, Bianco NE, Machado IV: Risk factors 1055 for dialysis-associated hepatitis C in Venezuela Muller M (abst) 489 Muller S (abst) 495 Muller V (abst) 498 MUller-Ruchholtz W (abst) 488 24 Mullins J See Bachman S et al 37:S-l25 Mullins ii See Barrett GL et a! 697 MUlsch A (abst) 700 Munaut C (abst) 508 Munck 0 (abst) 489 Mundel P (abst) 813 Muollo B See Fioretto P et al 488 Muthny FA (abst)

1764

Author Index: Vol. 41

Mutti A See Khalil-Manesh F et a! 1192 Myers BD See Scandling JD et al 840 Myers JC See Alvarez RJ et a! 14 Nadasdy T See Neufeld TK et a! 1222 Nafz B (abst) 490 Nagata M See Sakai T et al 533 Nahas AME: Growth factors and glomerular sclerosis 36:S-15 Nahman NS Jr., Leonhart KL, Cosio FG, Hebert CL: Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells 396 Naito S See Ogahara S et al 175 Najarian JS See Cheung AHS et a! 924 Nakada J See Nosaka K et al 73 Nakamoto Y See Komatsuda A et al 1204 Nakamura T, Miller D, Ruoslahti B, Border WA: Production of extracellular matrix by glomerular epithehal cells is regulated by transforming growth factor-/31

1213

Nakamura Y See Sakamoto H et a! 350 Nakazato Y See Sedor JR et al 595 Nankivell BJ, Fawdry RM, Harris DCH: Assessment of glomerular filtration rate in small animals by intra450 peritoneal 99mTc DTPA (Technical Note) 1447, 1447 Napodano P (abst) Narita I (abst) 697 Nasini MG (abst) 1441 507 Nassberger L (abst) Nast CC (abst) 700, 705 Nast CC See Ihm C-G et al 768 Natochin Y (abst) 478 Navar LG See Carmines PK et al 36:S-43 Nayak RC, Attawia MA, Cahill CJ, King GL, Ohashi H, Moromisato R: Expression of a monoclonal antibody (3G5) defined ganglioside antigen in the renal cortex 1638 Neild GH (abst) 695 Neilson EG See Alvarez RJ et al 14 Neilson EG See Heeger P et a! 220 Neufeld TK, Douglass D, Grant M, Ye M, Silva F, Nadasdy T, Grantham JJ: In vitro formation and expansion of cysts derived from human renal cortex epitheha! cells 1222 Neumayer H-H, Kunzendorf U, Schreiber M: Protective effects of calcium antagonists in human renal 36:S-87 transplantation Neusser M (abst) 495 Newman GE See Collins DM et a! 1292 Ng LL, Davies JE: Lipids and cellular Na/H antiport 872 activity in diabetic nephropathy Nicolosi G See Trevisan R et al 855 Niederreither K (abst) 706 Nielsen B (abst) 505, 506 758 Nielsen B See Parving H-H et a! Nielsen EM (abst) 511 Nielsen F (abst) 506 Nielsen PK (abst) 501, 502, 509 Nielsen SL (abst) 505 Njhei H See Ohashi K et a! 1646 Niimi K See Santos F et al 356 Nishi S See Hayashi H et al 749 Nishitani H See Shoji T et al 1653 Nishizawa Y See Shoji T et al 1653 479, 696 Nobiling R (abst) Nobiling R See Sakai T et al 533

Noble NA See Border WA et a! 566 Nogués X See SentI M et al 1394 Noh JW (abst) 1452, 1452 Noland TD See Takeda M et al 1713 500 Norby A (abst) Nord CE (abst) 503 Nordal KP (abst) 500, 509 Nordén G (abst) 509 Nord!ander M, Havu N: Effects of chronic felodipine treatment on renal function and morphology in SHR 36:S-100 Nordlander M See DiBona GF et al 36:S-1 Nordlander M See Elmfeldt D et at 36:S-54 NØrgaard K See Borch-Johnsen K et al 719 Noronha IL (abst) 480, 490, 497, 700 Nosadini R See Fioretto P et a! 813 855 Nosadini R See Trevisan R et al Nosaka K, Nakada J, Endou H: Cisplatin-induced alterations in renal structure, ammoniagenesis and gluconeogenesis of rats 73 Nouwen EJ (abst) 1435 Novarini A (abst) 1445 Nussenblatt R See Choyke PL et a! 1595 Nutting CW, Islam S, Ye M, Batile DC, Daugirdas JT: The vasorelaxant effects of acetate: Role of adeno166 sine, glycolysis, lyotropism, and pH, and Ca2 509, 703 Nyberg G (abst) 508 Nylanden P (abst) 501 Nystrand R (abst) Oberle G (abst) 495 Oberleithner H (abst) 497 Obrant K (abst) 507 O'Brien RC See Cooper ME et al 898 Ocal G (abst) 1471 O'Dea F See Barrett BJ et a! 1274 O'Donoghue DJ See Brenchley PB et al 933 Oe LP See Kouw PM et al 440 Oe PL (abst) 1438 482 Oehring H (abst) Oemar BS (abst) 697 O'Farrell SC See Heeger P et al 220 Ofstad J, Horvei G, Kvam Fl, MØrkrid L, Sekse I, Svarstad E, Iversen BM: Glomerular hemodynamics in progressive renal disease 36:S-8 Ogahara S, Naito S, Abe K, Michinaga I, Arakawa K: Analysis of HLA class II genes in Japanese patients 175 with idiopathic membranous glomerulonephritis 490, 698 Ogilvie A (abst) Ogino S See Hayashi H et a! 749 Ogura Y See Ohashi K et al 1646 Oh DJ (abst) 1455, 1455 Oh HY (abst) 1450, 1452 Oh MS (abst) 1450 Ohashi H See Nayak RC et a! 1638 Ohashi K, Hara M, Kawai R, Ogura Y, Honda K, Nihei H, Mimura N: Cervical discs are most susceptible to beta2-microg!obulin amyloid deposition in the vertebral column 1646

OiteT(abst)

697

Oko A (abst) 488 Okten A (abst) 1471 Olausson M (abst) 509 O!bricht CJ, Geissinger B, Gutjahr E: Renal hypertrophy in streptozotocin diabetic rats: Role of proteo966 lytic lysosomal enzymes Ølgaard K (abst) 501, 501, 502, 508, 509, 512

Author Index: Vol. 41

Olgemoller B (abst) Olivieri 0 (abst) Oliviero P See Beuve Cs et a! Olthof CG See Kouw PM et a! Omboni S See Parati G et a!

705 1446

37:S-45 440 37:S-24

Onat 0 (abst) 1469 O'Neil LAJ: How does interleukin-1 activate cells7 546 Onen K (abst) 1466, 1466, 1467 Oozma G (abst) 1472 Opocher G See Fioretto P et al 813 Oreopoulos DG See Breborowicz A et a! 1280 Ørskov H See Flyvbjerg A et al 805 Orzincolo C (abst) 1441 Osborne-Pellegrin M See Anidjar S et a! 37:S-61 703 Østerby R (abst) Østerby R See Walker JD et al 741 Ostman A See Heldin C-H et a! 571 Ostrow B See Tilton RG et al 778 Ott! I (abst)

496

Oudar 0 See Shahedi M et al Owens DR See Vora JP et al Oz H (abst) Ozaip A (abst) Ozcebe 0 (abst) Ozdamar K (abst) OzdemirO(abst) Ozdemir Y (abst) Ozdogan E (abst) Ozener (abst)

455

OzgozUkara A (abst) OzgUn S (abst) Paape ME (abst) Padalino PK See Koenig KG et a! Padovese P (abst) Pai KS (abst) Paillard M See Houillier P et al Palazzi P (abst)

829 1467 1471

1470, 1471, 1472 1467

1470, 1471, 1472 1469 1466, 1473 1470 1467

1470 1431 161

1443 1453 1182 1439

Pallone TL, Hyver SW, Petersen J: A model of the vol1366 umetrically-controlled hemodialysis circuit Pals SL (abst) 1438 Pancham R (abst) 1431 488 Panitz H (abst) 1446 Panzetta G (abst) 1443 Paoletti E (abst) 1446 Paolini F (abst) Parati G, Omboni S, Di Rienzo M, Frattola A, Albini F, Mancia G: Twenty-four hour blood pressure vari37:S-24 ability: clinical implications 1439 Parenti M (abst) 1274 Parfrey PS See Barrett BJ et al 1450 Park CG (abst) Park C-H (abst) 1448, 1449, 1460, 1460 1460 Park CJ (abst) 1455 Park CS (abst) 1460 Park CW (abst) Park HC (abst) 1449, 1460, 1465 1463 Park I(abst) Park IS (abst) 1448, 1455, 1464, 1464, 1465 Park JK (abst) 702, 1452, 1462 Park JS (abst)

Park KK(abst) Park MCH (abst) Park MH (abst) Park MI (abst) Park MS (abst) Park SB (abst)

1450, 1458 1453

1465

1452 1457 1458, 1459, 1459 1453, 1458, 1460

Park SE (abst) Park SH (abst)

1765 1457, 1461, 1461

1464 1457

Park SJ (abst)

Park S-K (abst) Park Y-H (abst) Park YS (abst) Parks JR See Coe FL et a! Parlongo S (abst)

1448, 1450, 1458 1460, 1465 1451, 1451, 1451

139 1442, 1443

Parving H-H, Gall M-A, SkØtt P, JØrgensen HE, LØkkegaard H, JØrgensen F, Nielsen B, Larsen S: Preva-

lence and causes of albuminuria in non-insulin-depen758 dent diabetic patients 719 Parving H-H See Borch-Johnsen K et a! 1483 Patrono C See Remuzzi G et al 496 Paul M (abst) 698 Pavenstädt H (abst) Pedersen E (abst) 505, 508, 508

Pedersen EB, SØrensen SS, Eiskjr H, Skovbon H, Thomsen K: interaction between cyclosporine and 36:S-82 felodipine in renal transplant patients 510 Pedersen RS (abst) Pederson MM, Hansen KW, Schmitz A, SØrensen K, Christensen CK, Mogensen CE: Effects of ACE inhibition supplementary to beta blockers and diuretics in 883 early diabetic nephropathy 847 Pederson MM See Hansen KW et a! 1394 Pedro-Botet J See SentI M et al Pedrotti A, Bonjour J-P, Guignard J-P: Protection from hypoxemia-induced renal dysfunction by the thio-

80 phosphate WR-2721 504 Pehrsson SK (abst) Pei Y, Hercz G, Greenwood C, Sherrard D, Segre G, Manuel A, Saiphoo C, Fenton 5: Non-invasive prediction of aluminum bone disease in hemo- and pen1374 toneal dialysis patients 1394 PelegrI A See SentI M et al 1041 Peltenburg HG See Kooman JP et al 1662 Penninckx R See Soupart A et al 1016 Perfumo F See Canepa A et a! 1081 Perico N See Gaspari F et a! 1662 Perier 0 See Soupart A et al 1445 Perinotto P (abst) Perrone RD: Means of clinical evaluation of renal dis36:S-26 ease progression 822 Persson B See Rudberg S et a! 512 Persson I-B (abst) Persson PB (abst) 481, 490 24 Peters J See Bachman S et a! 829 Peters JR See Vora JP et a! 1366 Petersen J See Pallone TL et a! 486 Petersen K (abst) 1445 Petrarulo M (abst) 1445 Petrini C (abst) 1029 Petruccelli D See Fernández JM et a! 504 Pettersson E (abst) 497 Pfaller K (abst) 497 Pfaller W (abst) 705 Pfeiffer C (abst) Pfeilschifter J (abst) 490, 491, 697 1452 Phan SR (abst) 600 Philippe C See Baud L et a! 1443 Piazza V (abst) Picardi L (abst) 1443 1442, 1442 Piccoli G (abst) 37:S-2 Pilowsky P See Arnolda L et a! 697 Pinerolo C (abst)

1766

Pinto J See Jones SL et at Pippin J See Reyes AA et al Pisetsky DS See Spurney RF et at Pizzonia JH (abst) Poggio F (abst) Poletti LF See Santos F et a! Ponticelli C (abst) Pontoriero G (abst) Pooth U (abst) Porn MT (abst) Post M (abst) Postma CT (abst) Postorino M (abst) Pouyssegur J (abst) Povisen JV (abst) Power DA (abst) Power DA See Batlmer PE et at Pozzi C (abst) Preisig R See Schaad HJ et at Pnigent A See Houillier P et a! Prins F (abst) Pritzl P (abst) Pritzl P See Floege J et a! Privitera M (abst) Proctor RK See Collins DM et al Provoost AP (abst) PrUtz K (abst) Pugliese F (abst) Pugliese F See Menè P et a! Pugliese G See Ido Y et at Pusey CD (abst) Pusey CD See Spencer SJW et at

Author Index: Vol. 41

1620 100 973

485 1443

356 1446 1444 483

1447, 1447 701 1436 1443

485

506, 509 699, 703, 703, 706 132

1442

420 1182

700 701 297 1444 1292 1437

506 1442 554 435 704 1059

Ramboer I, Bun P, Lacape G, Daret D, Lamaziere J-MD, Larrue J: Effects of monohydroxylated fatty acids on arterial smooth muscle cell properties 37:S-67 Ramirez G, Saba SR, Dietz JR, Vesely DL: Immunocytochemical localization of proANF 1-30, proANF 3 1-67, and atnial natriuretic factor in the kidney 334 Rannou F See Beuve CS et at 37:S-45 Rasmussen HH (abst) 511 Rasmussen K (abst) 502, 508, 508, 509 Rasmussen KC (abst) 508 Rasmussen LS (abst) 502 Rassier ME, McIntyre Si, Yamaki M, Takeda S, Lin J-T, Dousa TP: Isozymes of cyclic-3', 5'-nucleotide phosphodiesterases in renal epithelial LLC-PK1 cells 88 Ratcliffe PJ (abst) 481 Ratctiffe PJ See Tan CC et al 1581 492 Rauterberg EW (abst) Reboucas NA (abst) 485 Reddy R See Barrett BJ et al 1274 Redlak M (abst) 494 Rees AJ (abst) 704 Rees AJ See Spencer SJW et a! 1059 Reichel H (abst) 491 485 Reilly RR (abst) Rekola S (abst) 511, 511 Relander A (abst) 505 Remuzzi A (abst) 697 Remuzzi G (abst) 697 Remuzzi G, FitzGerald GA, Patrono C: Thromboxane synthesis and action within the kidney (Editorial 1483 Review) Remuzzi G See Fioretto P et al 813 Remuzzi G See Gaspari F et a! 1081 Renner EL See Schaad HJ et at 420 Rennke HG See Anderson S et al 891 486, 487 Repp H (abst) Resch K (abst) 698 Resnick L See Green DF et al 956 Ressem L (abst) 500 Reyes AA, Lefkowith J, Pippin J, Klahr S: Role of the 5-lipooxygenase pathway in obstructive 100 nephropathy Reyes AA, Martin D, Settle S. Klahr S: EDRF role in renal function and blood pressure of normal rats and rats with obstructive uropathy 403 Rha SY (abst) 1456 Rhee SK (abst) 1448, 1451 Ribstein J See Mimran A et al 37:S-l07 Riedel E (abst) 494 Riehi J (abst) 493 Riesco A (abst) 695 Rifici V See Gupta S et at 1161 Ringoir S See Vanholder R et at 1707 Rippe B See Haraldsson BS et al 310 Risler T (abst) 489, 495 Risler T See Erley CM et at 1297 Ritz E (abst) 478, 479, 485, 486, 488, 491,

Pussard E See Berdeaux A et at 37:S-29 1453 Pyun K-H (abst) Quamme GA: Free cadmium activity in renal epithelial 1237 cells is enhanced by Mg2+ depletion Quan ZY, Watser M, Hill GS: Adrenalectomy ameliorates ablative nephropathy in the rat independently of corticosterone maintenance level 326 1442 Quarello F (abst) Quarto Di Palo F (abst) 1439 494 Quednau B (abst) Raasveld MHM (abst) 1438 Raatz SK See Satahudeen AK et at 183 Rabbia C (abst) 1439 Rabelink AJ (abst) 1436 Radeke HH (abst) 698 Radermacher J, Klanke B, Schurek H-J, Stolte HF, Frolich JC: Importance of NO/EDRF for gtomerular and tubular function: Studies in the isolated perfused 1549 rat kidney Radice A (abst) 1442 Radounikli A (abst) 491 Raffelsiefer A (abst) 478 Raiftery M See Walker JD et al 741 489 Raghunath M (abst) 1445 Ragni G (abst) 496, 496, 496, 497, 498 483 Rivolta R (abst) Ragunath M (abst) 1439 701 Rizza V (abst) Rahilly MA (abst) 1445 Rahn KH (abst) 478, 493, 495 Rob PM (abst) 491 Raij L See Tolins JP et a! 1254 Roberts AB, McCune BK, Sporn MB: TGF-/3: RegulaRainer SP See Miller TE et al 1356 tion of extracetlular matrix 557 Rakhit A See Smith SR et al 199 Robertz-Vaupel C-M (abst) 480 Rambausek M (abst) 497, 498 Robey PG See Kopp JB et at 56

Author Index: Vol. 41

Robinson RR: From the President: The International 930 Society of Nephrology and Its Congresses Rocco MV, Chen Y, Goldfarb 5, Ziyadeh FN: Elevated glucose stimulates TGF/3 gene expression and bioac107 tivity in proximal tubule Rodela H See Breborowicz A et al 1280 Rodemann HP (abst) 482, 702, 703 Rodemann HP See Woithuis A et a! 124 698 Rodriguez-Puyol D (abst) 698 Rodriguez-Puyol M (abst) 483 Roggendorf M (abst) Roh JW (abst) 1450 Rolla D (abst) 1443 Romano U (abst) 1445 Rombolà G (abst) 1441 Romero J (abst) 491 Romero R See SentI M et a! 1394 Ronco C, Brendolan A, Feriani M, Milan M, Conz P, Lupi A, Berto P, Bettini MC, Greca GL: A new scmtigraphic method to characterize ultrafiltration in hollow fiber dialyzers 1383 Ronco P See Stefanovië V et a! 1571 Rootwelt K (abst) 500 Rosen VJ See Khalil-Manesh F Ct al 1192 Rosenberg ME See Correa-Rotter R et al 796 Rosenberg ME See Correa-Rotter R Ct a! 938 Rosenberg ME See Salahudeen AK et al 183 RosenlOf K (abst) Rosenzweig SA (abst) Rossi M (abst) ROssner S (abst)

499 697 1446 503

Rother K (abst) 496 Rothlein R, Wegner C: Role of intercellular adhesion molecule-i in the inflammatory response 617 Rotunno M (abst) 1439 Rouch AJ, Whitford GM, Campbell HT: Fluoride flux in the rabbit CCD: A pH-dependent event 342 699 Roy-Chaudhury P (abst) Roy-Chaudhury P See Balimer PE et al 132 Rubiés-Prat J See SentI M et a! 1394 Rudberg S, Persson B, Dahiquist G: Increased glomerular filtration rate as a predictor of diabetic nephrop822 athy—An 8-year prospective study Ruef C See Coleman DL et a! 604 1286 Ruffet M See Charra B et al Ruggenenti P See Gaspari F et a! 1081 973 Ruiz P See Spurney RF et a! 898 Rumble JR See Cooper ME et al 491 Rump LC (abst) 1213 Ruoslahti E See Nakamura T et al 698 Rupprecht HD (abst) Russo D (abst) 1445 1446 Russo R (abst) 149 Ryall RL See Grover PK et al Ryan US See Green DF et a! 1506 492 Rybczyñska A (abst) 1470, 1470 Saatci U (abst) Saba SR See Ramirez G et a! 334 Sabadini E (abst) 1445, 1447, 1447 455 Sachs C See Shahedi M et al 912 Sadler R See Bakris GL et al 1467 Sa1amer L (abst) Said R, Hamzeh Y, Said S, Tarawneh M, A1-Khateeb M: Spectrum of renal involvement in familial Medi414 terranean fever 414 Said S See Said R et a!

1767

Sainio K (abst) 696 Saiphoo C See Pei Y et a! 1374 Saitou T See Hayashi H et al 749 Sakai T, Lemley Ky, Hackenthal E, Nagata M, Nobiling R, Kriz W: Changes in glomerular structure following acute mesangial failure in the isolated per533 fused kidney Sakamoto H, Sasaki 5, Nakamura Y, Fushimi K, Marumo F: Regulation of endothelin-1 production in cultured rat mesangial cells 350 Sala MR (abst) 1446 Salahudeen AK, Hostetter TH, Raatz SK, Rosenberg ME: Effects of dietary protein in patients with 183 chronic renal transplant rejection 1441 Salit M (abst) Salmonson T (abst) 500, 504, 504 1444 Salnitro F (abst) Sa!vadeo A (abst) 1443 499 Samuelsson 0 (abst) San A (abst) 1472, 1473 1599 Sandberg SM See Ciresi DL et al 506 Sandgren H (abst) 506 Sandhagen B (abst) Sandrini S (abst) 1440, 1440 891 Sandstrom Di See Anderson S et a! 920 Sandvik L See Dahl-JØrgensen K et al 973 Sanfihippo F See Spurney RF et al 1447 Sanna G (abst) 1446 Santoro A (abst) Santos F, Chan JCM, Krieg RJ, Niimi K, Hanna JD, Welions MD, Poletti LF: Growth hormone secretion from the pituitary cells in chronic renal 356 insufficiency 485 Sardet C (abst) 1466 Sariyar M (abst) 1467 Sarsmaz N (abst) Sasaki S See Sakamoto H et al 350 37:S-19 Sassard J See Barrès C et a! 704 Savi!l i (abst) Savill J: Apoptosis: A mechanism for regulation of the 607 cell complement of inflamed glomeruli 1175 Savolainen Mi See Hörkkö S et al 65 Sawada S See Lemoine R et al Scaini P (abst) 1440, 1440 Scandling JD, Myers BD: Glomerular size-selectivity and microalbuminuria in early diabetic glomerular 840 disease Schaad Hi, Frey BM, Renner EL, Preisig R, Frey FJ: Microsomal liver function declines steadily after kid420 ney grafting: A three to five year follow-up 704 Schaefer RM (abst) Schafer JA, Hawk CT: Regulation of Na channels in the cortical collecting duct by AVP and mineralocor255 ticoids (Editorial Review) 199 S chaffer AV See Smith SR et al 1437 Schalekamp MADH (abst) 1430 Schalkwijk I (abst) 1701 Schambelan M See Al-Uzri A et al 492 Schellenberg A (abst) Scherberich JE (abst) 479, 488, 492, 492, 498 486 Scherberich I (abst) Scheuermann E (abst) 479, 498 495, 495 Scheyerl F (abst) 481 Schild C (abst) 1588 Schimpf BA See Zager RA et al 481, 698 Schindler R (abst)

1768

Author Index: Vol. 41

486 Schirop T (abst) Schleicher E (abst) 705 483 Schlipkoter U (abst) Schiondorif D See Gupta S et at 1161 Schiondorif D See Wilkes BM et a! 992 Schlottmann K (abst) 492 SchlUter H (abst) 493 Schmiedeke T (abst) 495 Schmitt H (abst) 483, 493 Schmitz A See Pederson MM et at 883 Schmouder RL, Strieter RM, Wiggins RC, Chensue SW, Kunkel SL: In vitro and in vivo interleukin-8 production in human renal cortical epithelia 191 Schneider H See Kouw PM et al 440 Schneider M (abst) 488 Schoeppe W (abst) 479, 483, 483, 491, 492, 492,

495, 497, 498, 696 Schollmeyer P (abst) 489, 491, 698 479 Schollmeyer PJ (abst) Scholz H (abst) 493 493 Schongen N (abst) Schoots AC (abst) 1433 Schrama E (abst) 1432 Schrama YC (abst) 1433 Schramek H (abst) 497 Schreiber A (abst) 491 Schreiber M See Neumayer H-H et at 36:S-87 Schreiner GF See Takahashi K et al 1245 Schrier RW (abst) 699 Schrier RW See Almeida ARP et a! 1494 Schrier RW See Hensen J et at 1333 Schroder K See Hensen J et a! 1333 1432 Schroijen VJHM (abst) Schubert I (abst) 492 Schulze-Lohoff E (abst) 490, 698 Schurek H-J See Radermacher J et at 1549 Schuster MJ (abst) 491 Schwaabe S (abst) 705 Schwab SJ See Collins DM et al 1292 491 Schwertfeger E (abst) Schwietzer G (abst) 483, 497 Schwoerbel C (abst) 492 496 Scigalla P (abst) Scotari F (abst) 1440, 1440 Sedor JR. Nakazato Y, Konieczkowski M: Interteukin-i and the mesangial cell 595 1443 Segagni S (abst) 1439, 1439 Segoloni GP (abst) Segre G See Pei Y et a! 1374 Seifert RA See Flôege S et al 297 Sekse I See Ofstad S et al 36:S-8 1473 Setcuk Y (abst) Selvi A (abst) 1440 Semplicini A See Trevisan R et al 855 SentI M, Romero R, Pedro-Botet 5, PelegrI A, Nogués X, Rubiës-Prat J: Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure 1394 1445 Sepe V (abst) Sepe V See Canton AD et al 951 Serdengeçti K (abst) 1466, 1466 Serventi M (abst) 1445 1467 Setenay Dincer K (abst) Setti G (abst) 1440, 1440 Settle S See Reyes AA et al 403 Sever L (abst) 1467, 1467

Sever M (abst) 1471 1466, 1473 Sever MS (abst) 487 Sewing KF (abst) Shahedi M, Laborde K, Lelongt B, Oudar 0, Sachs C: A cytochemical procedure for &termination of

Na,K-ATPase activity in MDCK cells (Technical 455 Note) Shan Z See Gupta S et al 1161 Shanley PF See Ford DM et al 1606 Shapiro SI See Hiatt WR et al 1613 Sharma A (abst) 704 Shaw S (abst) 481, 493 Sherrard D See Pei Y et at 1374 Shibata T See Lernoine R et al 65 Shimada H See Lemoine R et at 65 Shimizu F (abst) 697 Shin HS (abst) 1459 Shin JH (abst) 1448 Shin SH (abst) 1448, 1451 Shin YT (abst) 1448, 1451 Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H: Impaired metabolism of high density tipo1653 protein in uremic patients Short CD See Brenchley PE et at 933 Sick H (abst) 484 Sicuso C (abst) 1442 Sidoti A (abst) 1445 Sieberth H-G (abst) 482, 483, 493 Sieberth H-G See Ittel TH et at 1340 Siegbahn A See Heldin C-H et at 571 Siems W (abst) 494 Siffert W (abst) 494 Silomon JF (abst) 483 Silva F See Neufeld TK et at 1222 Simon SM See Freyss-Beguin MM et a! 37:S-79 Simon T See Choyke PL et al 1595 Simonsen 0 (abst) 504 Simonson MS, Jones JM, Dunn MJ: Cytosolic and nuclear signaling by endothelin peptides: Mesangial re542 sponse to glomerular injury Sinaz A (abst) 1472 Sindel S (abst) 1472 Singhal PC, Gibbons N, Abramovici M: Long term effects of morphine on mesangial cell proliferation and matrix synthesis 1560 Sinico RA (abst) 1442, 1447, 1447 Sisson-Ross S See Vernier RL et at 1070 Sixma ii (abst) 1436 510 Sjogren B (abst) 508 Skaarup P (abst) Skietbo M (abst) 505 Skietboe M (abst) 505 Skøtt P See Parving H-H et a! 758 Skovbon H See Pedersen EB et at 36:S-82 493 Skrasting A (abst) Skroch D (abst) 495 485 Slayman CW (abst) Slikkerveer A (abst) 1432 Stuiter HE See Frenken LAM et at 384 Sluiter HE See Huysmans FTM et at 36:S-106 Sluiter HE See van Hamersvelt HW et a! 36:S-73 Smet RD See Vanholder R et al 1707 Smith SR, Creech EA, Schaffer AV, Martin LL, Rakhit A, Douglas FL, Kiotman PE, Coffman TM: Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity 199

Author index: Vol. 41

Smith SR See Tilton RG et a! 778 Smits P (abst) 1436 Smogorzewski M See Chervu I et a! 1501 Sohn SH (abst) 1453, 1456, 1458, 1458, 1459, 1463, 1463 Solbu D (abst) 507 Soleimani B See Esnault VLM et al 1304 Soliani F (abst) 1441 Son HS (abst) 1454 Sone M (abst) 494 1455, 1455 Song JS (abst) Sonmez G (abst) 1472 Sonsuz A (abst) 1466 502 SØrensen JP (abst) SØrensen K See Pederson MM et al 883 SØrensen SS See Pedersen EB et al 36:S-82 Sorokin L, Ekblom P: Development of tubular and gbmerular cells of the kidney 657 Soupart A, Penninckx R, Stenuit A, Perier 0, Decaux G: Treatment of chronic hyponatremia in rats by intravenous saline: Comparison of rate versus magnitude of correction 1662 1470, 1470 Soylemezogtu 0 (abst) 698 Späth M (abst) Spencer SJW, Burns A, Gaskin G, Pusey CD, Rees AJ: HLA class II specificities in vasculitis with antibodies 1059 to neutrophil cytoplasmic antigens 1446 Spongano M (abst) Sporn MB See Roberts AB et a! 557 701 Spring J (abst) Spurney RF, Fan P-Y, Ruiz P, Sanfihippo F, Pisetsky DS, Coffman TM: Thromboxane receptor blockade reduces renal injury in murine lupus nephritis 973 Sredni B See Gafter U et a! 143 Stahl RAK (abst) 483, 483, 491, 495, 696 Steen Olsen T (abst) 499, 508 Stefani A (abst) 1441 Stefanovië V, Vlahovië P, Ardaillou N, Ronco P, Ardailbou R: Cell surface aminopeptidase A and N activities in human glomerular epithelial cells 1571 Steffensen U (abst) 506 Steffes MW See Lane PH et a! 1085 Steffes MW See Mauer SM et a! 736 Steffes MW See Vernier RL et a! 1070 494, 495, 495 Steffgen J (abst) 1435 Stegeman CA (abst) 502, 506 Stegmayr B (abst) Stehouwer CDA (abst) 1433 Stein G (abst) 482 Steinhauer HB (abst) 489 Steinhausen M (abst) 492 Stentoft J (abst) 511 Stenuit A See Soupart A et al 1662 Stenver D (abst) 505, 506 Stenvinkel P (abst) 503 Sterzel RB (abst) 490, 698, 698 Sterzel RB See Kashgarian M et a! 524 Sterzel RB See Madri JA et at 523 Stock! F (abst) 495 Sto!te HF See Radermacher J et al 1549 Stone BG See Tolins JP et al 1254 Stone E See Barrett BJ et al 1274 Störkel S (abst) 492 Storm T (abst) 503 499, 508 Strandgaard S (abst) 510 Strate M (abst) 1447 Stratta P (abst)

1769

Strauer BE (abst) 487 Streefland C (abst) 1437 Streekstra G (abst) 1436 Strieter RM (abst) 695 Strieter RM See Schmouder RL et a! 191 StrOmbom U (abst) 511 Stroomer MKJ (abst) 1437 1436 Struijk DG (abst) Struijk DG, Koomen GCM, Krediet RT, Arisz L: Indirect measurement of lymphatic absorption in CAPD 1668 patients is not influenced by trapping Strutz F (abst) 495 Struyker-Boudier HAJ See Kooman JP et a! 1041 Sucak U (abst) 1472 Sudhir K See Angus JA et a! 37:S-73 Suk CW (abst) 1456 Sukhatme VP (abst) 698 Sukhatme VP: The Egr transcription factor family: From signal transduction to kidney differentiation 550 1467 SUkrU Sever M (abst) Sun MJ See Alvarez RI et a! 14 Sun MJ See Heeger P et a! 220 Sun X (abst) 1438 Sung KH (abst) 1449, 1460, 1465 1449 Sung KT (abst) Sungur C (abst) 1469, 1471, 1472 Sutherland DER See Cheung AHS et al 924 Sutherland DER See Mauer SM et al 736 Suzuki Y See Hayashi H et a! 749 Svaland M (abst) 500 Svalander C (abst) 511 Svarstad E See Ofstad J et a! 36:S-8 Swynghedauw B See Beuve CS et a! 37:S-45 Symreng T, F!anigan MJ, Lim VS: Ventilatory and metabolic changes during high efficiency hemo1064 dialysis 494 Szczepañska-Konkel M (abst) 487 Szewczyk Z (abst) Takahashi K, Kato T, Schreiner GF, Ebert J, Badr KF: Essential fatty acid deficiency normalizes function 1245 and histology in rat nephrotoxic nephritis Takeda M, Breyer MD, Noland TD, Homma T, Hoover RL, Inagami T, Kon V, Fredin DM, Hellings SE: Endothelin- 1 receptor antagonist: Effects on endotheun- and cyclosporine-treated mesangial cells 1713 Takeda S See Rassier ME et at 88 Tamsma JT (abst) 1432 Tan CC (abst) 481 Tan CC, Ratcliffe PJ: Rapid oxygen-dependent changes in erythropoietin mRNA in perfused rat kidney: Evi1581 dence against mediation by cAMP Tan K-C See Moore KP et at 1543 1442 Taranta A (abst) Tarantino A (abst) 1439 414 Tarawneh M See Said R et al 877 Tariq T See Lopes de Faria JB et al Tarjan E, Denton DA, Ferraro T, Weisinger RS: Effect of CRF, ACTH and adrenal steroids on sodium in37:S-97 take and excretion of rabbits 1443 Taroto G (abst) 1676 Tasby J See Truong LD et at 1204 Tashima Y See Komatsuda A et al 155 Taskinen E See Isoniemi HM et a! 1473 Tatlikazan L (abst) 492 Tauber M (abst) 1543 Taylor GW See Moore KP et al

1770

Author Index: Vol. 41

Telaferli A (abst) 1467 1438 ten Berge R.JM (abst) 495 Tepel M (abst) ter Wee PM See Kouw PM et at 440 511 Terkildsen K (abst) 56 Termine JD See Kopp JB et a! 1471 Terzlog!u 0 (abst) Teschner M (abst) 704 Tevfik Ecder S (abst) 1467 Thaiss F (abst) 483, 483, 491, 495, 696 Thea A (abst) 1447 Thiel G (abst) 498 Thiel G See Bock HA et al 275 Thien Th (abst) 1436 489 Thoenes W (abst) Thomas D See Vora JP et a! 829 Thomas GJ See Davies M et a! 671 Thomsen K See Pedersen EB et al 36:S-82 Thurau K (abst) 494 511 Thysell H (abst) Tiengo A See Fioretto P et a! 813 Tilocca P (abst) 1447 Tilton RG, Baier LD, Harlow JE, Smith SR, Ostrow E, Williamson JR: Diabetes-induced glomerular dysfunction: Links to a more reduced cytosolic ratio of

NADH/NAD

778

Tilton RG See Ido Y et al 435 502 Timpka T (abst) 1466 Tinaztepe K (abst) Tiselius H-G (abst) 510 Tizianello A (abst) 1446 Toback FG: Regeneration after acute tubular necrosis 226 (Nephrology Forum) Tolbert E See Lax DS et al 1527 Tolins JP, Stone BG, Raij L: Interactions of hypercholesterolemia and hypertension in initiation of glomer1254 ular injury 1431 Tomiyama T (abst) Tomooka S See Border WA et a! 566 Tonbul HZ (abst) 1472, 1473 1470 Topaloglu R (abst) 699 Topley N (abst) Törnroth T (abst) 508 Torrat J-C See Charra B et al 1286 Torre L See Gaspari F et al 1081 481, 1443 Travaglini M (abst) Trevisan R, Nosadini R, Fioretto P, Semplicini A, Donadon V, Doria A, Nicolosi G, Zanuttini D, Cipollina MR, Lusiani L, Avogaro A, Crepaldi G, Viberti GC: Clustering of risk factors in hypertensive insulin-dependent diabetics with high sodium-lithium 855 countertransport Trevisan R See Fioretto P et al 813 Triolo G (abst) 1439 Troschau G (abst) 497 Troy JL See Anderson S et a! 891 Truong LD, Farhood A, Tasby J, Gillum D: Experimental chronic renal ischemia morphologic and immunologic studies 1676 Tsai P (abst) 699 Tsalamandris C See Jerums G et a! 904 Tsapas G See Magoula I et at 1349 Tschernko E (abst) 496 496 Tschope W (abst) Tsobanelis T (abst) 496 Tufve son U (abst)

507

Tufvesson G (abst) TUlbek MY (abst) Turner N (abst)

Tuna (abst) Turgan c (abst) Turner N (abst) Tvedt KE (abst) Ucci AA See Vlahakos DV et al Ucmakli E (abst) Ueno M See Hayashi H et al lJlkü U (abst) Ulirich KJ (abst) Ulrichs K (abst) Ulukutlu L (abst) Unlubozkurt M (abst) Usadel K-Fl (abst)

UsluS(abst)

501 1468 1471

1466, 1473 1469, 1470, 1471, 1472 704 500 1690 1468

749 1466, 1466 478, 479, 480 488 1467 1467

486 1467 482

VaaBen W (abst) 1441 Valpondi P (abst) van Acker BAC (abst) 1437, 1437 van Bommel EFH (abst) 1434 van Bortel L (abst) 1433 1434 van Bortel LMAB (abst) van Bortel LMAB See Kooman JP et at 1041 van Buren M (abst) 1434 Van De Voorde J (abst) 1432 van de Wiel BA (abst) 1431 van den Born J (abst) 1432 van den Born J, van den Fleuvel LPWJ, Bakker MAH, Veerkamp JH, Assmann KiM, Berden JHM: A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats 115 van den Dobbeisteen MEA (abst) 695, 1435

van den Heuvel LPWJ See van den Born J et at 115 van den Ouweland AMW (abst) 1430 van der Horst MLC (abst) 1431 van der Hoven B (abst) 1434 van der Meulen J (abst) 1438 van der Wal A (abst) 1430 van der Woude FJ (abst) 695, 1431, 1435 van Diemen-Steenvoorde R (abst) 1430 1438 van Diepen FNJ (abst) van Es LA (abst) 695, 1431, 1435 van Es LA: Pathogenesis of IgA nephropathy (Nephrol1720 ogy Forum) van Es PN (abst) 1436 van Gompel APM (abst) 1430 van Goor H (abst) 1431 van Hamersvelt HW, Sluiter HE, Wetze!s JFM, Koene RAP, Huysmans FTM: Is natriuresis on felodipine due to reversal of the renal effects of 36:S-73 angiotensin II van Hamersvelt HW See Huysmans FTM et al 36:S-106 van HooffJP (abst) 1433, 1434, 1435 van Hooff JP See Kooman JP et a! 1041 1434 van Leengoed LAMU (abst) van Olden RW (abst) 1433 van Oost BA (abst) 1430 van Os CH (abst) 1434 van Rooyen N (abst) 1430 van Tol A (abst) 1438 van Willebrand E See Isoniemi HM et at 155 Vane! T See Charra B et al 1286

Author Index: Vol. 41

Vanholder R, Hoefliger N, Smet RD. Ringoir S, Vogeleere P: Extraction of protein bound ligands from azotemic sera: Comparison of 12 deproteinization 1707 methods (Technical Note) 1433 Vanuytsel J (abst) Vasilakakis DM, D'Haese PC, Lamberts LV, Lemoniatou E, Digenis PN, Broe MED: Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis 1400 Vavasour HM See Barrett BJ et al 1274 vd Born J (abst) 1432 vd Woude FJ (abst) 1432 Veerkamp JH See van den Born Jet al 115 1439 Vegeto A (abst) Vehaskari VM See Bonilla-Felix M et a! 1150 Veis JH See Berl T et al 37 Verbeke M (abst) 1432 Vercellone A (abst) 1439, 1439, 1447 Vernier RL, Steffes MW, Sisson-Ross 5, Mauer SM: Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus 1070 1435 Verstrepen W (abst) Vesely DL See Ramirez G et a! 334 Viberti G See Jones SL et a! 1620 Viberti GC See Lopes de Faria JB et at 877 Viberti GC See Mauer M et a! 717 Viberti GC See Messent JWC et a! 836 Viberti GC See Trevisan R et al 855 Viberti GC See Walker JD et a! 741 1446 Viganà E (abst) Viganô G See Gaspari F et a! 1081 Villa G (abst) 1443 Virotta G See Gaspari F et a! 1081 Virtanen I See Korhonen M Ct a! 641 Vitale C (abst) 1445 Vitulo F (abst) 1444 Viahakos DV, Foster MH, Adams S, Katz M, Ucci AA, Barrett KJ, Datta SK, Madaio MP: Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites 1690 V!ahovië P See Stefanovi V et a! 1571 Vogeleere P See Vanholder R et al 1707 495 Vogt A (abst) Voisard R (abst) 483 Volkmann R (abst) 500, 512 von dem Borne AEGKr (abst) 1431 von der Mark H See von der Mark K et a! 632 Von der Mark K (abst) 696 von der Mark K, von der Mark H, Goodman S: Cellular response to extracellular matrix 632 Vora JP, Dolben J, Dean JD, Thomas D, Williams JD, Owens DR, Peters JR: Renal hemodynamics in newly 829 presenting non-insulin dependent diabetes mellitus

VosPF(abst)

1435

Vosbeck K (abst) 697 Vrtovsnik F, El Yandouzi EH, Le Grimellec C, Friedlander G: Sphingomyelin and cholesterol modulate sodium coupled uptakes in proximal tubular cells 983 488 Waaga A-M (abst) 496 Wagner C (abst) 705 Wagner E (abst) 496, 496 Wagner J (abst) 501, 509 Wahlberg J (abst) Wakai S, Magil AB: Focal glomerulosclerosis in idio428 pathic membranous glomerulonephritis 1204 Wakui H See Komatsuda A et a!

Waldegger S (abst) Waldherr R (abst)

1771 488

480, 490, 497, 700, 701

Walker JD, Close CF, Jones SL, Raiftery M, Keen H, Viberti GC, Østerby R: Glomerular structure in type-i (insulin-dependent) diabetic patients with normo- and microalbuminuria 741 Walser M See Quan ZY et al 326 Wande! E (abst) 487 Waniewski J See Heimburger 0 et a! 1320 Wanner C (abst) 698 Wantzin P (abst) 502 Ward JE See Angus JA et a! 37:S-73 Ward RA (abst) 482 Warram JH See Barzilay J et a! 723 492 Wasewicz M (abst) Watanabe Y, Kashihara N, Makino H, Kanwar YS: Modulation of glomerular proteoglycans by insulinlike growth factor-i 1262 Waterloos M (abst) 1432 Watson H See Bailmer PE et al 132 Watson ML, Macnicol AH, Allan PL, Wright AF: Effects of angiotensin converting enzyme inhibition in 206 adult polycysic kidney disease Webb DR See Coe FL et a! 139 Weber BK See Ballmer PE et a! 132 620 Weber M: Basement membrane proteins 1437 Weber RFA (abst) 702, 1432, 1432 Weening JJ (abst) 617 Wegner C See Rothlein R et al Wehrle-Haller B (abst) 701 Wehrmann M (abst) 484 Weidmann P (abst) 481, 493 Weidmann P See Blumberg A et al 369 Weier S (abst) 492 Weinlich M (abst) 1444 Weinreich T (abst) 479 Weis H (abst) 497 Weisberg LS, Kurnik PB, Kurnik BRC: Radiocontrastinduced nephropathy in humans: Role of renal 1408 vasoconstriction Weisinger RS See Tarjan E et al 37:S-97 Weiss H (abst) 488 Weiss L (abst) 506 Weisstuch JM, Dworkin LD: Does essential hyperten36:S-33 sion cause end-stage renal disease9 699 Welcer ER (abst) 705 Weller A (abst) Wellons MD See Santos F et al 356 494 Wendel 0 (abst) 506 Wentzel T (abst) 497 Wenzel UO (abst) 484 Werle E (abst) 1320 Werynski A See Heimburger 0 et a! 506 Wessén P (abst) 511 Westberg G (abst) 699 Westenfelder C (abst) 571 Westermark B See Heldin C-H et al 497 Westphale H-J (abst) 695 Westwick J (abst) 1494 Wetzels JFM See Almeida ARP et al 862 Wetzels JFM See Elving LD et al 384 Wetzels JFM See Frenken LAM et a! 36:S-l06 Wetzels JFM See Huysmans FTM et al 36:S-73 Wetzels JFM See van Hamersvelt HW et a! 699 Wheeler DC (abst) 342 Whitford GM See Rouch AJ et a!

1772

Author Index: Vol. 41

Whitworth JA: Adrenocorticotrophin and steroid-induced hypertension in humans 37:S-34 507 Widerøe TE (abst) 512 Widstam-Attorps U (abst) 488 Wiccel A (abst) Wieslander J (abst) 511 1452, 1452 Wiggins RC (abst) Wiggins RC See Schmouder RL et al 191 Wijnen JAG See Kooman JP et at 1041 Wikstom B (abst) 501 WikstrOm B (abst) 500, 501, 504, 504, 506, 507, 509 WiktrOm B (abst) 512 Wilkes BM, Kaplan R, Mento PF, Aynedjian HS, Macica CM, Schiondorif D, Bank N: Reduced glomerular thromboxane receptor sites and vasoconstrictor responses in diabetic rats 992 Williams JD (abst) 699 Williams JD See Vora JP et al 829 Williams R See Moore KP et at 1543 Williamson JR See Ido Y et at 435 Williamson JR See Tilton RG et a! 778 497 Willinger CC (abst) Windus DW See Delmez JA et al 1023 Winkler D (abst) 481 Winther K (abst) 505, 506 Wirth S (abst) 481 Wirtz C (abst) 478 Wiseman M See Jones SL et at 1620 Wissmann C (abst) 486 Wolf G See Heeger P et al 220 WOll E (abst)

488

Woithuis A (abst) 702 Woithuis A, Boes A, Rodemann HP, Grond J: Vasoactive agents affect growth and protein synthesis of cul124 tured rat mesangial cells Woo HJ (abst) 1455 Woo JY (abst) 1448, 1464, 1464 Wood J See Moore KP et at 1543 Woun KK (abst) 1456 699 Woytacha DR (abst) 484 Wrigge P (abst) Wright AF See Watson ML et at 206 Wright CE See Angus JA et at 37:S-73 Wunderle W (abst) 484 1435 Xiaosheng Y (abst) 1471 Yalcinkaya F (abst) 1472 Yamac K (abst) Yamakawa M See Shoji T et a! 1653 Yamaki M See Rassier ME et at 88 Yamamoto T See Border WA et at 566 Yamamoto T See Kawasaki K et at 1517 Yamaner S (abst) 1471 Yanagisawa H, Morrissey J, Yates J, Hayes C, Klahr S: Protein increases glomerular eicosanoid production and activity of related enzymes 1000

1455 1460

Yang CW (abst) Yang KH (abst) Yang Sil (abst)

Yang WS (abst) Yaoita E See Kawasaki

Yard

K et at

BA(abst)

1457, 1461, 1461 1453 1517

1431

Yasavill U (abst) Yates J See Yanagisawa H et al Yavuz M (abst) Ye M See Neufeld TK et al Ye M See Nutting CW et at Yergok YZ (abst) Yi GW (abst) Yi Y (abst) Yildiz I (abst) Yilmazlar T (abst) Ylänne J See Korhonen M et al Yong HS (abst) Yoon J (abst) Yoon JB (abst) Yoon SA (abst) Yoon YS (abst) 1448,

1469, 1470, 1471, 1472 1000

1466, 1468 1222 166 1468 1448, 1451 1458 1467 1473 641

1456 1462 1449, 1449 1448, 1464

1455, 1457, 1460, 1460, 1463, 1464, 1464, 1464, 1464, 1464, 1465 Floege J et 297

See at See Johnson R et at 590 Yoshioka T, Fogo A, Beckman JK: Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion 1008 Young MF See Kopp JB et at 56 Yu SH (abst) 1455, 1455 Yurtkuran M (abst) 1466, 1468 Zabaleta ME See Muller GY et at 1055 Zachariae H (abst) 508 Zager RA, Bredl CR, Schimpf BA: Direct amphotericin B-mediated tubular toxicity: assessments of selected 1588 cytoprotective agents Zahner G (abst) 483, 696 Zanner S (abst) 698 Zanussi C (abst) 1439 Zanuttini D See Trevisan R et at 855 Zaoui P See Himmelfarb J et at 388 Zayas MA See Anderson S et a! 891 Zeh K (abst) 496 Zeier M (abst) 498 Zerwekh JE See Koenig KG et at 161 Zidek W (abst) 493, 495 484 Ziegler R (abst) Zimmerman G (abst) 705 Ziyadeh FN See Rocco MV et at 107 Zoccali C (abst) 1442, 1443, 1444 697 Zoja C (abst) Zucchelli P (abst) 1446 1436 Zwaginga JJ (abst) 1438 Zweegman S (abst) Yoshimura A Yoshimura A